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1 INTRODUCTION 
1.1 Overview 
Cardiovascular diseases are a major source of mortality in the industrialized world. In 
the years 2004 to 2006, 41% of the cases of death of the 65- to 84-years-olds in the 
European Union were caused by cardio- or cerebrovascular events. Among these, the 
most frequent disease was ischemia of the heart with 17% (Niederlaender, 2006). 
There have been many attempts to reduce cardiovascular morbidity and mortality, 
either by primary prophylaxis (minimizing risk factors), or by treatment of already 
diseased patients. Primary prophylaxis, however, is the more reasonable way from an 
economic point of view, too. Acute cardiovascular events like myocardial infarction 
or stroke frequently result from atherosclerosis (Ross, 1999). Thus, prevention of 
atherosclerosis is one of the first steps in primary prophylaxis of cardiovascular 
morbidity. Apart from age, obesity, cigarette smoking, hypertension and diabetes 
mellitus, high serum low density lipoprotein-cholesterol (LDL-C) has been identified 
as a main risk factor for atherosclerosis (Ames et al., 1993; Ross, 1999; Law and 
Wald, 2002; Singh and Jialal, 2006). High serum LDL-C results mostly from dietary 
fat intake and is positively correlated to cardiovascular mortality (Schaefer, 2002). 
Interestingly, there is a lower cardiovascular mortality in Southern Europe and 
especially France than in many other developed countries like Germany and Great 
Britain, despite the fact of a similar high consumption of dietary fat and serum 
cholesterol in all these populations. This paradoxical situation (the so-called “French 
paradox”) was attributed to the high consumption of red wine in France (Renaud and 
de Lorgeril, 1992). Various studies on the impact of red wine on different 
cardiovascular parameters have shown that beneficial red wine effects could not be 
attributed to its alcoholic content, but rather to its polyphenolic components (e.g. 
Fitzpatrick et al., 1993; Wollny et al., 1999). Some of the examined parameters that 
were improved by polyphenolic agents are linked to the oxidative homeostasis of the 
body. Oxidative stress seems to be crucial in the pathogenesis of hypertension 
(Lassègue and Clempus, 2003) and atherosclerosis (Singh and Jialal, 2006), which 
often underlie cardiovascular diseases. It was proposed that a modulation of the 
oxidative state is responsible for the beneficial effect of polyphenolic agents present 
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in red wine and other beverages (Freedman et al., 2001; Al-Awwadi et al., 2004). 
NADPH oxidases, xanthine oxidase and uncoupled endothelial nitric oxide synthase 
(eNOS) are contributors to the generation of reactive oxygen species (ROS) causing 
oxidative stress in vasculature. As a consequence, changes in the expression or 
activity of these enzymes have immense effects on vascular homeostasis. In the last 
years, especially the role of NADPH oxidases in cardiovascular diseases has been 
highlighted. For this reason, NADPH oxidases are also relevant targets of 
investigations on the French paradox. The aim of this study was to evaluate the effects 
of polyphenolic beverages like red wine and purple grape juice on the expression and 
activity of NADPH oxidases in the aorta of the rat. 
 
1.2 Clinical Implications of Reactive Oxygen Species 
Hypertension is an important risk factor for the development and progression of 
atherosclerosis, which can result in acute cardiovascular events like ischemia of the 
heart, brain or extremities and succeeding infarction (Ross, 1999). Oxidative stress 
due to excessive ROS production leads to nitric oxide (NO) breakdown, which results 
in reduced vasorelaxation and, therefore, hypertension. ROS directly influence the 
vascular contractility, too. Furthermore, hypertensive damage of vessels is a 
consequence of exceeding ROS formation (Touyz, 2004). The destructive processes 
involved in hypertensive vascular damage include deposition of oxidized LDL-C and 
extracellular matrix in the vessel wall, proliferation of vascular smooth muscle cells, 
and monocyte invasion across the endothelial barrier. Finally, atheromata develop as a 
sign of atherosclerosis. Clinical manifestations like myocardial infarctions originate 
from sudden disruption of these plaques, which can be induced by mechanical forces 
of the blood flow with hypertensive blood pressure (Stokes et al., 2001). 
As described above, oxidative stress seems to be crucial in the development of 
cardiovascular diseases based on hypertension. Nevertheless, clinical trials on a 
possible beneficial effect of dietary antioxidants (vitamin E, vitamin C, β-carotene) 
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were disappointing (e.g. Rapola et al., 1997; Yusuf et al., 2000)1. Therefore, research 
has focussed on a decrease of ROS generation as a possible way of reducing 
cardiovascular mortality. 
 
1.3 French Paradox 
1.3.1 Background 
High dietary intake of saturated fat and elevated serum cholesterol are associated with 
a high incidence of cardiovascular diseases. Nevertheless, epidemiological 
investigations showed that there is a lower cardiovascular mortality in France than, 
for example, in Germany or Great Britain, despite a similar high consumption of 
dietary fat in these populations. The World Health statistics from 1989 noticed a 
yearly coronary heart disease mortality of 78 per 100000 men in Toulouse, France, 
and of 348 per 100000 men in Belfast, UK. Mean serum cholesterol was 230 mg/dl 
for Toulouse and 232 mg/dl for Belfast (World Health Organisation, 1989). That 
surprising situation, commonly termed as the “French paradox”, was attributed to the 
high red wine consumption in France (Renaud and de Lorgeril, 1992). Newer data 
from the European statistical system Eurostat show similar regional differences for 
causes of death in Europe. From 2004 to 2006, the highest rate of fatal ischemic heart 
disease in 65- to 84-years-old residents was found in Estonia with 2305 male and 
1318 female per 100000. In France, only 402 male and 169 female per 100000 died 
from this disease. That was the lowest rate in the European Union. All in all, Northern 
and Eastern Europe (Baltic states, Czech Republic, Slovakia) had a much higher 
incidence of fatal ischemic heart disease than Southern Europe (France, Portugal, 
Spain, Italy). In countries like Germany (874 male, 524 female per 100000) and Great 
Britain (1100 male, 602 female per 100000), deaths from ischemic heart disease were 
a little more frequent than in the European average (788 male, 451 female per 
100000). The complete data can be obtained from Eurostat, Luxembourg, and was 
summarized by Niederlaender (2006). 
                                                 
1 A great variety of clinical trials on these dietary antioxidants were reviewed by Kritharides and 
Stocker (2002). 
  4
The reciprocal correlation between red wine intake and cardiovascular mortality was 
easily detected, but it is not as easy to prove the supposed causal relationship between 
high red wine intake and reduced morbidity. Several in vitro and in vivo studies have 
tried to illuminate this appealing field of research. 
 
1.3.2 Ethanol or Red Wine Polyphenols? 
The first arising question is which red wine component might be responsible for its 
beneficial effect on the cardiovascular system. In healthy volunteers, alcohol was able 
to increase serum concentrations of high density lipoprotein-cholesterol (HDL-C)2 
that is known to be antiatherogenic by transporting cholesterol from peripheral tissues 
to the liver (Rimm et al., 1999). In apolipoprotein E-deficient mice, which serve as a 
disease model for atherosclerosis, both red wine and ethanol elevated serum HDL-C 
levels, whereas dealcoholized red wine did not (Bentzon et al., 2001). Alcohol also 
seems to inhibit platelet aggregation (Renaud and de Lorgeril, 1992). This is 
consistent with the observation that alcoholics die rarely from ischemic diseases in 
comparison to non-alcoholics, but more often from hemorrhagic strokes (Díaz et al., 
2003; Iso et al., 2004). Many epidemiological case control studies only assessed 
alcohol consumption but not its distribution to different beverages. They showed that 
moderate alcohol consumption reduced incidence and recurrence of myocardial 
infarctions (Gaziano et al., 1999; Hines et al., 2001; de Lorgeril et al., 2002). 
Mukamal et al. (2003) examined the correlation between consumption of different 
alcoholic beverages (beer, red and white wine, liquor) and found a reduction of 
nonfatal myocardial infarctions in all groups. 
                                                 
2 In the blood, cholesterol and triglycerides are transported in the core of lipoproteins, which are made 
water-soluble by an outer shell of phospholipids. Lipoproteins are classified by their density. LDL (low 
density lipoprotein) provides the periphery of the body with cholesterol, whereas HDL (high density 
lipoprotein) transports cholesterol from peripheral organs back to the liver. The LDL-C serum level 
correlates with the risk for atherosclerosis. Conversely, high HDL-C serum levels correlate with a low 
risk for atherosclerosis. For further information, see one of the plenty of textbooks of clinical 
pathology. 
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However, in a couple of experimental studies trying to explain the mechanism of the 
French paradox, alcohol alone failed to exhibit the same beneficial effects as red wine 
(e.g. Fitzpatrick et al., 1993; Wollny et al., 1999). These findings led to the hypothesis 
that these effects are caused by another large group of red wine components, the 
polyphenols. These compounds are found in many plants including grapes. The most 
common polyphenols in red wine are resveratrol, quercetin, catechin, curcumin, rutin, 
kaempferol, tannins, anthocyanins, caffeic acid and gallic acid (Tapiero et al., 2002). 
The beneficial effect of red wine is mainly ascribed to these antioxidant compounds. 
Therefore, research does not only focus on red wine, but also on certain polyphenols 
alone or on other polyphenolic beverages like purple grape juice or green and black 
tea. 
 
1.3.3 Role of Lipoproteins 
Considering the pathogenesis of atherosclerosis, which mostly underlies 
cardiovascular events, there are different parameters that could play important roles in 
the French paradox mechanism. HDL-C has antiatherogenic properties, whereas 
LDL-C, especially in its oxidized form, acts proatherogenic (Stocker and Keaney, 
2004). As described above, serum HDL-C levels seem to be elevated by ethanol but 
not by polyphenols. In hamsters with atherosclerosis induced by a high-fat diet, serum 
LDL-C levels were decreased, and the oxidation of LDL-C was decelerated by in vivo 
application of purple grape juice and red wine with and without alcohol (Vinson et al., 
2001). The oxidation of LDL-C was reduced by red wine but not by dealcoholized red 
wine in apolipoprotein E-deficient mice, a disease model for atherosclerosis (Bentzon 
et al., 2001). This was confirmed for dealcoholized red wine in Sprague Dawley rats, 
in which quercetin and catechin did not change LDL-C oxidation, too (Benito et al., 
2004). However, a mixture of these two red wine polyphenols was able to diminish 
LDL-C oxidation in Wistar rats fed with a high-fat diet (Fremont et al., 1998). In 
contrast to the findings of Bentzon et al. (2001), Stocker and O’Halloran (2004) 
reported a reduction of LDL-C oxidation after administration of dealcoholized red 
wine to apolipoprotein E-deficient mice. Nevertheless, red wine did not affect LDL-C 
oxidation products in humans (Ziegler et al., 2005). 
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These partially controversial results might be due to different study designs, but they 
also prompt to investigate other vascular parameters to elucidate the mechanism of the 
French paradox. 
 
1.3.4 Reactive Oxygen Species in the French Paradox 
Reactive oxygen species (ROS) play a physiological role not only in host defence 
(phagocytic respiratory burst), but also in normal cell metabolism (cell growth, cell 
aging and apoptosis, cell migration) (Stocker and Keaney, 2004). There are ROS 
producing enzymes (NADPH oxidases, xanthine oxidase, uncoupled nitric oxide 
synthase), and enzymes that eliminate ROS (superoxide dismutase, catalase, 
peroxidases). ROS strongly react with biomolecules like DNA, proteins, lipids and 
carbohydrates. If exceeding ROS production and / or diminished endogenous 
antioxidants disturb the physiological balance, potentially harmful oxidative stress 
will occur (Sies, 1991). The latter plays an important role in the pathomechanism of 
cardiovascular dysfunction. 
In the group of ROS, there are free radicals and nonradical oxidants. Free radicals, 
e.g. the superoxide anion (O2–), the hydroxyl radical (OH) and nitric oxide (NO), 
contain one or more unpaired electrons. When two radicals react with each other, they 
link their unpaired electrons to a covalent bond and form a nonradical molecule. That 
is the case in the breakdown of the radical NO by the radical superoxide, which 
results in the nonradical, but highly reactive oxidant peroxynitrite. A free radical may 
also react with a nonradical molecule to form a new radical, frequently followed by a 
chain reaction. An example relevant for the vasculature is the oxidation of lipids that 
often leads to a chain reaction with production of more and more oxidized lipids. 
Examples of nonradical oxidants are hydrogen peroxide (H2O2), hypochlorite (–OCl), 
hypochlorous acid (HOCl) and peroxynitrite (ONOO–) (Stocker and Keaney, 2004). 
NADPH oxidases, xanthine oxidase and uncoupled eNOS are the major sources of 
ROS in the vasculature. Xanthine oxidase catalyzes the oxidation of hypoxanthine to 
xanthine and of xanthine to uric acid with hydrogen peroxide as a by-product. There 
is evidence in literature that xanthine oxidase is involved in endothelial dysfunction 
(Guthikonda et al, 2003). Nevertheless, its role in the French paradox has not been 
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analyzed closely yet. Endothelial NO synthase (eNOS) generates NO from the 
substrate L-arginine, but it can also produce superoxide and hydrogen peroxide 
instead of NO, a process that is called uncoupling of eNOS (Mayer et al., 1991; 
Pritchard et al., 1995) and that has been associated with hypertension (Landmesser et 
al., 2003). Many research groups investigated the role of eNOS in the French paradox, 
but a real correlation could never be proven (cf. chapter 1.3.5). As an endogenous 
antioxidant defence mechanism, superoxide dismutase (SOD) metabolizes superoxide 
to hydrogen peroxide, which is decomposed to water and oxygen by catalase or used 
to oxidize other substrates. Dietary-derived antioxidants include vitamin C 
(ascorbate), vitamin E (α-tocopherol) and a number of polyphenols (Stocker and 
Keaney, 2004).  
It was shown that exceeding vascular ROS production and oxidative stress are 
implicated in the pathogenesis of atherosclerosis, hypertension and diabetic vascular 
dysfunction (Taniyama and Griendling, 2003). ROS, especially superoxide, lead to 
the breakdown of endothelium-derived NO (Afanas’ev, 2004). Thus, they play a key 
role in vascular pathophysiology and may be an important factor in the decryption of 
the French paradox. In Sprague Dawley rats with insulin resistance, which is 
associated with enhanced superoxide production in the thoracic aorta, ingestion of red 
wine polyphenols with and without ethanol decreased superoxide production in 
comparison to controls; ethanol alone did not affect superoxide production in aorta 
(Al-Awwadi et al., 2004). In humans, purple grape juice diminished the formation of 
superoxide both after in vitro application on platelets and in vivo uptake for 14 d 
(Freedman et al., 2001). Not only grape-derived beverages but also green and black 
tea, which are known to contain a great variety of polyphenols, exhibited this effect in 
vitro (Ying et al., 2003). 
ROS also play an important role in tumorgenesis (McCord, 2000). This leads to the 
hypothesis that polyphenolic beverages might exhibit a similar protective effect on 
morbidity caused by malignancy as on cardiovascular morbidity. Indeed, 
epidemiological studies have revealed a preventive effect of red wine but not other 
alcoholic beverages on lung cancer (Ruano-Ravina et al., 2004) and prostate cancer 
(Schoonen et al., 2005). In a follow-up study including 24523 persons in Denmark, 
Grønbaek et al. (2000) found a lower relative risk for dying from cancer in wine 
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drinkers, but not in persons drinking beer or spirits regularly. In addition, the 
polyphenolic antioxidant resveratrol seems to be protective against various cancer 
types (Aziz et al., 2003). 
Since ROS are a main link between pathogeneses of cardiovascular and malignant 
diseases (McCord, 2000), the hypothesis that oxidative stress plays a key role in the 
French paradox is convincing. Oxidative stress can be due to increased oxidant 
generation, declined endogenous antioxidant defence, or both. The investigation of 
endogenous antioxidants is complicated by the fact that defence mechanisms are 
induced by oxidative stress. Thus, an enhancement of antioxidant enzymes may 
indicate either a better protection or a greater need of these enzymes (Beckman and 
Ames, 1998). 
 
1.3.5 Nitric Oxide and Endothelial Dysfunction 
Endothelium-derived nitric oxide (NO), formerly known as endothelium-derived 
relaxing factor (EDRF)3, plays a crucial role in maintaining normal vascular function 
and structure. It acts as a vasodilator and inhibits platelet aggregation, monocyte 
adhesion, and proliferation and migration of vascular smooth muscle cells (VSMC). 
NO breakdown due to ROS and concomitant formation of peroxynitrite results in 
endothelial dysfunction with an enhanced risk of cardiovascular diseases. The term 
endothelial dysfunction includes a state of impaired vascular tone, monocyte adhesion 
to the vascular wall and platelet aggregation. It is one of the earliest events in 
atherogenesis (Ross, 1999). 
NO is generated from the substrate L-arginine by NO synthases (NOS). NO interacts 
with its receptor, soluble guanylyl cyclase, and generates cGMP which mediates 
many effects of NO. In absence of their substrate L-arginine or their activating 
cofactor tetrahydrobiopterin (e.g. because it was oxidated by ROS), NO synthases can 
become uncoupled, i.e., they transfer electrons to molecular oxygen instead of L-
                                                 
3 Robert F. Furchgott described the discovery of EDRF and its identification as NO in his Nobel 
lecture for receiving the Nobel Prize in Physiology or Medicine 1998 together with Ferid Murad and 
Louis J. Ignarro (Furchgott, 1998). 
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arginine, and thereby they generate superoxide instead of NO (Mayer et al., 1991; 
Pritchard et al., 1995). Under certain conditions, there can be a partial uncoupling, and 
NO synthases produce superoxide and NO concurrently. As described above, these 
two molecules combine to peroxynitrite. Some cardiovascular risk factors like 
hypercholesteremia, diabetes and hypertension seem to be involved in the uncoupling 
of NOS (Griffith and Stuehr, 1995; Hemmens and Mayer, 1998; Davis et al., 2001; 
Stocker and Keaney, 2004). Figure 1 summarizes the impact of oxidative stress on 
endothelial function. 
 
 
 
 
 
 
 
Figure 1: Oxidative stress and endothelial dysfunction – a simplified scheme. Pathological 
states are associated with Nox activation, oxidative stress and succeeding reduced NO-
bioavailability, i.e. endothelial dysfunction. 
 
In summary, NO is essential for endothelial function. An initial event in atherogenesis 
seems to be endothelial dysfunction, which is attributed to a lack of NO (Beckman et 
al., 1990). NO may either be generated to a lesser extent by NO synthase (NOS), or be 
depleted by interaction with superoxide and subsequent formation of peroxynitrite 
(Hemmens and Mayer, 1998; Afanas’ev, 2004).  
Wallerath et al. (2003) reported that application of red wine on human endothelial 
cells from the umbilical vein enhanced the expression of the endothelial NOS isoform 
(eNOS), both on mRNA and protein level. Certain polyphenols like resveratrol and 
caffeic acid also increased eNOS protein expression, whereas others like quercetin 
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and catechin did not (Wallerath et al., 2005). In addition, red wine and resveratrol 
were able to elevate NOS activity (Wallerath et al., 2002; 2003). Leikert et al. (2002) 
could not show an effect of resveratrol on NOS activity in the same cells, but 
dealcoholized red wine enhanced both NOS activity and eNOS protein expression. In 
vivo experiments with Wistar rats revealed that dealcoholized red wine increased 
NOS activity (Bernátová et al., 2002), but in a similar study eNOS protein expression 
was not affected (Ralay Ranaivo et al., 2004).  
NO acts as a vasodilator and inhibits platelet aggregation, monocyte adhesion, and 
VSMC proliferation and migration. In the literature, the impact of red wine on 
vasofunction and platelets was assessed with many experimental designs (e.g. 
Fitzpatrick et al., 1993; Freedman et al., 2001). The insufficient inhibition of 
monocyte adhesion and VSMC proliferation and migration by NO was examined by 
measuring the extent of atherosclerotic plaques (Vinson et al., 2001). 
Common experimental setups for endothelial function are vessel studies in organ bath 
chambers. Fitzpatrick et al. (1993) applied the substances of interest directly on rat 
aortic rings. Both red wine and purple grape juice improved endothelium-dependent 
vasorelaxation in response to acetylcholine, whereas ethanol and white wine had no 
effect. Interestingly, an extract from grape skins but not from grape pulp could copy 
the red wine effect. Additionally, various polyphenols were applied on aortic rings. 
Quercetin and tannic acids improved vasorelaxation, whereas resveratrol and malvidin 
did not. In rings from rat mesenteric and femoral artery, dealcoholized red wine 
enhanced relaxation (Zenebe et al., 2003; Duarte et al., 2004). The latter substance 
had a similar relaxing effect when administered to Wistar rats 7 d before the 
organbath experiments were performed (Diebolt et al., 2001). In contrast to pure 
ethanol and white wine, feeding of red wine with and without alcohol enhanced 
bleeding time and decreased platelet adhesion to fibrillar collagen in Sprague Dawley 
rats (Wollny et al., 1999). Osman et al. (1998) fed purple grape, orange and grapefruit 
juice to monkeys and dogs; only the first one inhibited platelet aggregation in both 
species. The in vitro aggregation of human platelets was also reduced by application 
of purple grape juice. This could be confirmed in vivo by demonstrating that after 14 d 
of regular grape juice intake platelet aggregation was inhibited (Freedman et al., 
2001). 
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Results concerning the influence of red wine on atherosclerotic plaque formation are 
rare and controversial. Vinson et al. (2001) reported that in hamsters with preexisting 
atherosclerosis, the plaque size could be decreased by a 10 weeks feeding period with 
red wine with and without alcohol, purple grape juice, and ethanol alone. These 
findings could be confirmed in apolipoprotein E-deficient mice which were fed with 
dealcoholized red wine (Stocker and O’Halloran, 2004). However, Bentzon et al. 
(2001) found no effect at all on the plaque size in the same animal model when 
feeding red wine, dealcoholized red wine or ethanol, although a positive effect of red 
wine and ethanol on HDL-C levels and on LDL-C oxidation could be demonstrated. 
 
1.3.6 Role of NADPH Oxidases 
The ROS producing NADPH oxidases represent a relatively young field of research. 
Thus, there were only few attempts to elucidate the role of these enzymes in the 
French paradox, although the hitherto existing results are intriguing. 
NADPH oxidases (with their calatytic subunits that are called Nox) are the major 
ROS producing enzymes in the vasculature (Griendling et al., 2000), and they are the 
only ROS source studied in this work. It has been shown that resveratrol was able to 
inhibit in vitro Nox activity in rat aortae (Orallo et al., 2002) and in inflammatory 
macrophages from Wistar rats (Leiro et al., 2004). Apart from resveratrol, the 
polyphenols curcumin and rutin decreased Nox activity in human monocytes infected 
with Chlamydia pneumoniae, which seems to promote atherosclerotic lesions (Deby-
Dupont et al., 2005). In endothelial cells from bovine carotid artery, polyphenolic 
extracts from green and black tea diminished the protein expression of the Nox 
subunits p22phox and p67phox (Ying et al., 2003). 
 
1.4 The Family of NADPH Oxidases 
1.4.1 The Phagocytic NADPH Oxidase 
The first known nicotinamide adenine dinucleotide phosphate oxidase (NADPH 
oxidase) was the phagocytic one which is responsible for the microbicidal oxidative 
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burst in neutrophils, monocytes and macrophages – a major mechanism in host 
defence. The active phagocytic oxidase consists of six different subunits. The 
catalytic subunit Nox2 (also called gp91phox) and p22phox form the membrane-bound 
cytochrome b558, which is activated by assembly of the regulatory cytosolic subunits 
p47phox, p67phox, p40phox, and rac1 or rac2. The active enzyme, illustrated in Figure 
2A, rapidly produces great amounts of superoxide by electron transfer from NADPH 
to molecular oxygen (Babior, 2002) according to the following reaction: 
NADPH + 2O2 → NADP+ + 2O2– + H+. 
Nox2 has a size of approximately 65 kDa (Royer-Pokora et al., 1986) and is 
associated to the membrane of phagosomes by six transmembrane helices. It contains 
two hemes, one FAD and one NADPH binding site. The cytochrome b558 complex 
alone is inactive. The regulatory subunits p47phox, p67phox and p40phox are complexed 
in the cytosol. In activated phagocytes, an autoinhibitory domain in p47phox needs to 
be phosphorylated by proteinkinase C to make the binding to p22phox possible. 
Thereby, the whole cytosolic complex is recruited to the membrane (Groemping et al., 
2003). The subunit p67phox activates the electron transfer from NADPH to FAD 
(Nisimoto et al., 1999), and is the binding partner for rac, which is also necessary for 
oxidase activation (Lapouge et al., 2000). The last subunit, p40phox, is not required for 
Nox activity, but it facilitates the translocation of p47phox and p67phox to the membrane 
and enhances superoxide generation (Kuribayashi et al., 2002).  
Apart from phagocytes, the catalytic subunit Nox2 was also detected in different 
vascular cells, i.e. endothelial cells, VSMC and fibroblasts, and in the three layers of 
the vessel wall intima, media and adventitia (summarized by Lassègue and Clempus, 
2003). Some experiments indicate a role of Nox2 in vascular diseases: Firstly, its 
mRNA expression was enhanced in diabetes (Kusaka et al., 2004) and by oscillatory 
stress in endothelial cells (Hwang et al., 2003). Secondly, angiotensin II-induced left 
ventricular hypertrophy was not elicited in Nox2-deficient mice in comparison to wild 
type animals (Byrne et al., 2003). Finally, Nox2 (and p22phox) mRNA levels were 
correlated with the severity of atherosclerosis in human coronary arteries (Sorescu et 
al., 2002). 
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Figure 2: Vascular NADPH oxidases. A. Together with p22phox, the catalytic Nox2 (gp91phox) 
forms the membrane-bound cytochrome b558. Activation of the phagocytic NADPH oxidase 
requires the assembly with the cytosolic subunits p47phox, p67phox and p40phox, which are 
complexed in the cytosol, and rac. B. Active Nox1 and Nox4. NoxO1 and NoxA1 are 
homologues of p47phox and p67phox, respectively. Apart from p22phox, there is no evidence for 
Nox4-regulating subunits until now (modified from Opitz et al., 2007). 
 
1.4.2 Discovery of New NADPH Oxidase Isoforms  
In the late 1990’s, Suh et al. (1999) discovered Nox1, the first homologue of the 
catalytic Nox2. Since this time, five other catalytic subunits – Nox3, Nox4, Nox5, 
Duox1 and Duox2 – have been described. Nox1, Nox3 and Nox4 have approximately 
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the same size as Nox2 and a similar structure with six transmembrane α-helices, two 
hemes, the FAD and the NADPH binding site (Lambeth, 2004). Nox1 is mainly 
expressed in the colon (Suh et al., 1999), but also in endothelial cells, VSMC and 
adventitial fibroblasts (Sorescu et al., 2002). Nox3 was firstly cloned in fetal kidney 
(Cheng et al., 2001). Recently, Bánfi et al. (2004) found very high Nox3 mRNA 
levels in the inner ear. Geiszt et al. (2000) discovered Nox4 in renal tubule cells. 
Nox4 mRNA is also expressed in vascular endothelial cells, VSMC and adventitial 
fibroblasts (Sorescu et al., 2002). Additionally to the Nox2 homologous region, Nox5 
possesses a calcium-binding site by which it is regulated (Bánfi et al., 2001). Nox5 
mRNA was detected in spleen, sperm and fetal tissues (Cheng et al., 2001). There are 
two Nox2 homologues cloned from thyroid gland that also contain a calcium-binding 
site, one additional transmembrane α-helix and a peroxidase-like domain. Because of 
these two oxidase domains (NADPH oxidase plus peroxidase), they were called 
Duox1 and Duox2 (dual oxidase) (Dupuy et al., 1999). 
 
1.4.3 Vascular NADPH Oxidases 
NADPH oxidases represent a major source of ROS in the vasculature (Griendling et 
al., 2000). In contrast to phagocytes, which show an inducible Nox activity, vascular 
cells (endothelial cells, VSMC, fibroblasts) seem to have constitutively active 
oxidases, because they exhibit a basal superoxide generation. However, vascular Nox 
isoforms can also be activated, for example by angiotensin II (Lassègue et al., 2001; 
Rueckschloss et al., 2002). Apart from Nox2, the isoforms Nox1 and Nox4 were 
detected in non-phagocytic cells, too (Lassègue and Clempus, 2003). Newer data also 
showed mRNA expression of Nox3 (Zhang et al., 2006) and Nox5 in endothelial cells 
(Bánfi et al., 2001), but these isoforms were not investigated in this study. 
Nox1 is present in all vessel wall layers including endothelial cells, VSMC and 
fibroblasts (Sorescu et al., 2002). Like Nox2, it is localized at membranes together 
with p22phox, which is necessary for its function (Ambasta et al., 2004). Nox1 
possesses its own regulatory subunits. NoxO1 (Nox organizer 1) is almost identical to 
p47phox, but lacks the autoinhibitory region that prevents binding to p22phox in the 
inactive state (Takeya et al., 2003). Thus, it is prelocalized at the membrane together 
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with Nox1 and p22phox, even without cell activation (Cheng and Lambeth, 2004). 
NoxA1 (Nox activator 1) is a homologue of p67phox and activates Nox1 (Takeya et al., 
2003). A scheme of the active Nox1 enzyme complex is demonstrated in Figure 2B. 
Nox4 seems to be constitutively active. Furthermore, this enzyme seems to generate 
hydrogen peroxide in addition to superoxide. The common cytosolic subunits p47phox, 
p67phox, p40phox, rac, NoxO1 and NoxA1 are not required for the production of 
hydrogen peroxide by Nox4, and they are not able to increase its activity (Martyn et 
al., 2006). The only necessary subunit appears to be p22phox (Ambasta et al., 2004), 
but one or more Nox4-specific regulatory proteins might still be discovered in the 
future. Like Nox1, Nox4 is present in all vessel wall layers including endothelial cells, 
VSMC and fibroblasts (Sorescu et al., 2002). The enzyme complex of Nox4 is 
illustrated in Figure 2B. 
Vascular Nox isoforms are implicated in different cardiovascular diseases like 
hypertension, atherosclerosis, diabetic vascular diseases and heart failure 
(Rajagopalan et al., 1996; Azumi et al., 1999; Sorescu et al., 2002; Tojo et al., 2002; 
Sonta et al., 2004; Takayama et al., 2004). Nox-derived ROS are enhanced in genetic 
hypertension in spontaneously hypertensive rats (SHR) and in hypertension caused by 
angiotensin II (Rajagopalan et al., 1996; Zalba et al., 2000). In SHR, p22phox mRNA 
levels and media thickness are enhanced, and vasorelaxation is impaired in 
comparison to healthy controls. Treatment with angiotensin II-receptor antagonists 
improves vasofunction, and decreases media thickness, p22phox mRNA levels and Nox 
activity (Zalba et al., 2000). Angiotensin II is a major stimulus of Nox activity in the 
vasculature (Griendling et al., 1994). Its effects include VSMC hypertrophy 
(Geisterfer et al., 1988) and cellular inflammatory responses (Ferrario and Strawn, 
2006) which play important roles in atherogenesis. In fact, Nox activity and 
subsequent superoxide release is increased in vessels of rabbits with experimental 
atherosclerosis (Warnholtz et al., 1999). Azumi et al. (1999) demonstrated that 
p22phox, the binding partner of all vascular Nox isoforms, is enhanced in 
atherosclerotic human coronary arteries in all three layers of the vessel wall. Since 
atherosclerosis can result in acute vascular events, its association with vascular Nox 
isoforms may be of great importance for the manifestation of the French paradox.
  16
 
2 AIM OF THE THESIS 
The origin of the French paradox is yet not fully explained. Since the French people 
do not suffer from cardiovascular diseases as much as other people, and since 
endothelial dysfunction is one of the initial steps on the way to cardiovascular 
diseases, it seems reasonable to assume that the French develop less endothelial 
dysfunction. According to recent research, endothelial dysfunction and its sequelae, 
e.g. hypertension and atherosclerosis, can be considered as a state of oxidative stress. 
This has led to the hypothesis that red wine polyphenols somehow reduce oxidative 
stress, either by lessening the production of ROS, or by enhancing antioxidant defence 
mechanisms. NADPH oxidases are main contributors to superoxide and enhanced 
ROS production, and are associated to endothelial dysfunction. 
The purpose of this study, therefore, was to prove, whether the administration of  
polyphenolic beverages like red wine and purple grape juice will result in changes in 
Nox expression and / or activity in vitro and in vivo, which in turn would influence 
the oxidative homeostasis in the cardiovascular system.  
To achieve this goal, protein expression of three vascular Nox isoforms (Nox1, Nox2 
and Nox4) in aortic tissue homogenates and of Nox4 in rat aortic smooth muscle cells 
(A7r5) following administration of red wine or purple grape juice was assessed. 
Furthermore, Nox activity was determined via measurement of superoxide production 
in vitro in A7r5 cells and by performing isometric tension measurements on isolated 
thoracic aorta segments. The in vivo experiments were performed in healthy Wistar 
unilever rats (WUR) and in spontaneously hypertensive rats (SHR) which serve as a 
disease model for genetic hypertension. 
In more detail, the aim of this thesis was to answer the following questions:  
- How does red wine influence Nox activity and Nox protein levels in vitro? 
- Does in vivo administration of red wine result in a change of Nox expression 
and / or activity in vasculature? 
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- Is purple grape juice able to copy potential red wine effects? What is the role 
of ethanol in this context? 
- Is there a difference between healthy Wistar rats and cardiovascular stressed 
spontaneously hypertensive rats in response to polyphenolic beverages? 
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3 MATERIALS AND METHODS 
3.1 Ethical Approvals 
The experiments were approved by the Ethical Committee for Animal 
Experimentation of the Regional Commission, Giessen (Regierungspräsidium 
Giessen, Dezernat 25.3, Staatliches Amt für Lebensmittel-Überwachung, Tierschutz 
und Veterinärwesen), in accordance with the European Union Guidelines4. The 
experimental part of this study was performed at the Pharmacological Institute and at 
the animal house (“Zentrales Tierlabor”) of the Justus-Liebig-University in Giessen, 
Germany. 
 
3.2 Materials 
3.2.1 Antibodies 
The following antibodies were used for Western Blotting: anti-Nox1, anti-Nox2, anti-
Nox4, anti-β-actin and HRPO-conjugated secondary antibodies. Anti-Nox1 and anti-
Nox4 polyclonal antibodies were raised in our laboratories. The anti-Nox1 antibody 
was raised against the Nox1 amino acids 545-561, and the anti-Nox4 antibody against 
the N-terminal Nox4 amino acids 84-101 (Wingler et al. 2001). For the validation of 
the Nox4 antibody, peptide blocking, BLAST analysis and tissue expression patterns 
have been used by our group. Since its specificity has not been proven by MALDI-
TOF-analysis and in knockout mice yet, we describe the signals obtained with this 
                                                 
4 The original study design for the in vivo experiments intended to treat Wistar unilever rats (WUR) 
and spontaneously hypertensive rats (SHR) equally with red wine, ethanol, purple grape juice and 
sugared water. This design was approved for WUR. The committee did not approve treating SHR with 
potentially harmful beverages. The decision of rejection was made, because the animals already suffer 
from hypertension and should not be endangered by our treatment. Hence, we only fed them with 
purple grape juice, which was considered by the committee to be a harmless beverage. 
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antibody as immunoreactive signals. Anti-Nox2, anti-β-actin and the HRPO-
conjugated secondary antibodies are commercially available. 
Table 1: Antibodies used in this study. 
Primary Antibody Species Source Dilution 
Anti-Nox1 Rabbit Raised against Nox1-aa 545-561: 
RYSSLDPRKVQFYC (Wingler et al., 2001) 
1:25000 
Anti-Nox2 Mouse BD biosciences (Heidelberg) 1:1000 
Anti-Nox4  Rabbit Raised against Nox4-aa 84-101: 
RGSQKVPSRRTRRLLDKS (Wingler et al., 
2001) 
1:10000 
Anti-β-actin Rabbit Oncogene (San Diego, USA) 1:20000 
HRPO-conjugated anti-
rabbit 
Goat DAKO (Hamburg) 1:20000 
HRPO-conjugated anti-
mouse 
Goat DAKO (Hamburg) 1:2000 
 
3.2.2 Chemicals 
All the chemicals that were used in this study are listed in Table 2. 
Table 2: Chemicals and suppliers. 
Chemical Source 
β-Mercaptoethanol Carl Roth GmbH (Karlsruhe) 
Acrylamide (30%) with Bisacrylamide (0.8%) Carl Roth GmbH (Karlsruhe) 
Apocynin (4-hydroxy-3-methoxy-acetophenone) Calbiochem (Darmstadt) 
APS Merck (Darmstadt) 
BSA Sigma (Deisenhofen) 
CaCl2 Merck (Darmstadt) 
Carbogen (95% O2 / 5% CO2) Lindner (Bad Nauheim) 
Carbachol Sigma (Deisenhofen) 
Château de Mornag Mandagon red wine Langguth (Traben-Trarbach) 
CO2 Lindner (Bad Nauheim) 
Complete EDTA-free protease inhibitor set Roche Molecular Biochemicals (Mannheim) 
CuSO4 Merck (Darmstadt) 
Dulbecco’s modified Eagle’s medium Sigma (Deisenhofen) 
ECL Advanced Amersham Pharmacia Biotech (Freiburg) 
EDTA Sigma (Deisenhofen) 
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Chemical Source 
EGTA Sigma (Deisenhofen) 
Ethanol Merck (Darmstadt) 
Folin Ciocalteu’s phenol reagent Merck (Darmstadt) 
Fructose Sigma (Deisenhofen) 
Glucose Carl Roth GmbH (Karlsruhe) 
Glutamine Sigma (Deisenhofen) 
Glycerol Merck (Darmstadt) 
Glycine Carl Roth GmbH (Karlsruhe) 
HCl Merck (Darmstadt) 
KCl Carl Roth GmbH (Karlsruhe) 
KH2PO4 Carl Roth GmbH (Karlsruhe) 
Lucigenin Sigma (Deisenhofen) 
Methanol Merck (Darmstadt) 
MgSO4 Merck (Darmstadt) 
Na2CO3 Merck (Darmstadt) 
NaCl Merck (Darmstadt) 
NADPH Sigma (Deisenhofen) 
NaHCO3 Merck (Darmstadt) 
NaOH Carl Roth GmbH (Karlsruhe) 
Neutral red Sigma (Deisenhofen) 
Nitrogen Lindner (Bad Nauheim) 
Non-fat dry milk powder Nestlé (Glandale, USA) 
Penicillin Sigma (Deisenhofen) 
PeqGold protein marker IV prestained PeqLab Biotechnologie (Erlangen) 
Phenylephrine Sigma (Deisenhofen) 
Ponceau S Serva (Heidelberg) 
Protein extruded rodent diet No. 2019 Harlan Teklad (Borchen) 
Purple grape juice Lindavia (Lindau) 
Roti-Load Carl Roth GmbH (Karlsruhe) 
SDS Sigma (Deisenhofen) 
Sodium deoxycholate Sigma (Deisenhofen) 
Sodium tartrate Merck (Darmstadt) 
Sodium pyrophosphate Sigma (Deisenhofen) 
Streptomycin Sigma (Deisenhofen) 
TEMED Sigma (Deisenhofen) 
Trichloracetic acid Merck (Darmstadt) 
Tris Carl Roth GmbH (Karlsruhe) 
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Chemical Source 
Triton X 100 Serva (Heidelberg) 
Trypsin Sigma (Deisenhofen) 
Tween 20 Sigma (Deisenhofen) 
Vanadate Appli Chem (Darmstadt) 
 
3.2.3 Devices 
All technical devices used are listed in Table 3. 
Table 3: Technical devices. 
Device Source 
Analytical balance AT 250 E. Mettler (Zürich, Switzerland) 
Analytical balance M 5 E. Mettler (Zürich, Switzerland) 
Centrifuge 5804 Eppendorf (Hamburg) 
Electrophoresis system Biorad (München) 
Fluoroscan FL Thermo labsystems (Vantaa, Finland) 
Isolated organ apparatus IOA 5306 FMI Föhr Medical Instruments (Seeheim) 
KL 2 shaker E. Bühler (Bodelshausen) 
Kodak EDAs 290 camera system Kodak (New Haven, USA) 
Kodak Image Station 440 CF NEN Life Science Products, Inc. (Zaventem, 
Belgium) 
Ohaus Explorer pro animal balance, EP 2102 C  EducaTec AG (Döttingen, Switzerland) 
Power Supply SX mighty slim Hoefer (San Francisco, USA) 
Semi-dry transfer cell, Trans Blot SD Biorad (München) 
Spectra max 340 microplate reader Molecular Devices (Sunnyvale, USA) 
Thermomixer Compact Eppendorf (Hamburg) 
Varioclav Steam Sterilizer H+P Labortechnik GmbH (Oberschleißheim) 
Vortex VF 2 Janke und Kunkel IKA (Staufen) 
Water bath type 1013 Gesellschaft für Labortechnik mbH (Burgwedel) 
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3.2.4 Software 
The software used in this study and for preparing this thesis is listed in Table 4. 
Table 4: Computer Software. 
Software Source 
Adobe Photoshop 7.0 Adobe System (San José, USA) 
IBJ-Amon and -Bemon vitro dat 3.4 Jaeckel (Hanau) 
Kodak 1D Image Analysis Eastman Kodak company (New Haven, USA) 
Microsoft Office for Mac 2004 Microsoft Deutschland GmbH (Unterschleißheim) 
Prism Graph Pad 4.0 Graph Pad Software (San Diego, USA) 
Softmax Pro 1.2.0 Molecular Devices (Sunnyvale, USA) 
 
3.3 Cell Culture 
Two methods were employed in the in vitro part of this study, namely protein analysis 
and a superoxide assay. Both were performed in A7r5 cells, a rat aortic smooth 
muscle cell line.  
The A7r5 cells were cultured in low glucose (1 g/l) Dulbecco’s modified Eagle’s 
medium, which was supplemented with 10% heat inactivated calf serum, 100 U/ml 
penicillin, 100 µg/ml streptomycin and 2 mM glutamine. Confluent cells were 
incubated for 72 h with red wine (Château de Mornag-Mandagon, vintage 2002, 
produced from the grapes Carignan and Cinsault [vine variety]) in a concentration of 
5% (v/v) in phosphate buffered saline (PBS), purple grape juice (Lindavia Rote 
Traube Direktsaft) in a concentration of 10% (v/v), an ethanol solution of 0.6% (v/v), 
or the vehicle PBS, respectively. These concentrations are approximately 10% of the 
concentrations used in the in vivo experiments5. The ethanol solution served as control 
for the diluted red wine, PBS was used as the appropriate control for purple grape 
juice. Subsequently, cells were washed three times with PBS and further treated as 
described in chapter 3.8.3, 3.8.4 and 3.9. 
                                                 
5 Plasma concentrations of polyphenols reach about 10% of the ingested amount of polyphenols, 
depending on the chemical structure of the different polyphenols (Duthie et al., 1998). 
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PBS (Phosphate buffered saline), pH 7.3 
KCl 2.7 mM 
KH2PO4 1.5 mM 
NaCl 137 mM 
Na2HPO4 8 mM 
 
3.4 Animals 
Healthy Wistar unilever rats (HsdCpb:WU) and spontaneously hypertensive rats 
(SHR/NHsd) were obtained from Harlan Winkelmann GmbH in Borchen, Germany.  
For the experiments, 12 weeks-old WUR and SHR were maintained in conventional 
temperature (22 °C) and humidity (60%) controlled animal facilities in a 12 h light / 
dark cycle. The animals were subdivided into groups of 2-3 in regular polycarbonate 
rodent cages (type IV). They were fed ad libidum with standard rodent chow (Harlan 
Teklad Nr. 2019) containing 20% protein, 55% carbohydrate, and 9% fat. After an 
adaption period of one week, the rats were weighed at day 0 and 14 of a two weeks 
feeding period.  
 
3.5 Experimental Design of the in vivo Study 
The in vivo study also consisted of two experimental parts, i.e. protein analysis and 
organ bath studies. For protein analysis in WUR, one control group and four test 
groups were formed. These five groups were divided into two treatment clusters, each 
consisting of the control group and two of the test groups. As a result, from each 
animal of the control group two data sets of control values were obtained by two 
succeeding experimental procedures. With SHR, only two parallel groups were 
formed, one control and one test group. 
The same distribution of animals and groups was used for organ bath studies with 
SHR and WUR. However, in organ bath experiments with WUR, the control groups 
were combined to one single group to which the four test groups were compared. 
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With SHR, there were only two parallel groups, one control and one test group (cf. 
Table 5). 
In total, 52 animals were used, 40 WUR and 12 SHR. WUR were randomly assigned 
to five different treatment groups, i.e., eight animals per group. Accordingly, SHR 
were distributed to two equally sized treatment groups. 
For technical reasons, only 30 WUR were randomly assigned to the organ bath 
studies. Hence, in organ bath studies, each treatment group consisted of six animals. 
Table 5: Treatment groups. 
Animals Treatment 
Cluster 
Treatment / Feeding Number of Animals  
   Protein Analysis Organ Bath 
Experiments 
WUR I Red wine dilution (1:1) 8 6 
  Ethanol 6% 8 6 
  Watera 4 3 
 II Purple grape juice 8 6 
  Sugar solution 8 6 
  Watera 4 3 
SHR - Purple grape juice 6 6 
  Water 6 6 
a In data analysis, the water-treated animals were merged to form the control group. 
 
3.6 Feeding Protocol 
After the adaption period, the animals were randomly assigned to different treatment 
groups. In this study, “treatment” stands for a controlled fluid intake, i.e., all animals 
received only pre-defined liquids. In the first treatment cluster, WUR were treated 
with red wine (Château de Mornag-Mandagon) diluted 1:1 in water, or 6% ethanol in 
water according to the ethanol concentration of the diluted red wine. Water served as 
control in a third group. Red wine was diluted 1:1, because such a dilution has been 
described to be effective in literature (Bentzon et al., 2001; Vinson et al., 2001), and 
because pure red wine certainly does not meet the condition of “moderate alcohol 
consumption”. 
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In the second treatment cluster, WUR were fed with purple grape juice (“Lindavia 
Rote Traube Direktsaft”), or a sugar mixture consisting of the main carbohydrate 
components of this juice, fructose (76 g/l) and glucose (77 g/l), dissolved in water 
(concentrations according to those in the juice). The control group received water. 
Purple grape juice was not diluted, because it is not thought to be harmful. Osman et 
al. (1998) administered pure juice to dogs and monkeys without reporting any harmful 
effect. Furthermore, a concentration of purple grape juice twice as high as that of red 
wine seemed reasonable after evaluation of the in vitro studies on concentration-
dependency performed in this work (cf. chapter 4.1.2). In this study, we tried to 
answer the question, whether purple grape juice in principle exhibits similar effects as 
red wine. If the answer to this question would have been “yes”, further experiments 
about dose-dependency in vivo would have followed. 
In statistical analyses of organ bath studies, the six water-fed animals served as 
control for all other treatment groups. However, within each treatment cluster, the 
groups fed with ethanol or sugar solution acted also as an active control. So the effect 
of red wine was controlled by ethanol and the effect of purple grape juice was 
controlled by the sugar solution. 
SHR received purple grape juice or water only, because the local committee for 
animal protection did not approve further experiments with potentially harmful 
beverages in these cardiovascular stressed animals (see chapter 3.1). 
All beverages were administered ad libidum. The ingested amounts of chow and 
liquids were estimated by periodical weighing of the bottles and the chow. After a 
14 d period of feeding, the animals were killed by carbon dioxide (CO2) inhalation, 
and the aortae were dissected immediately. 
 
3.7 Organ Preparation 
Immediately after killing the animals by CO2 inhalation, the thoracic aortae including 
the aortic arches were carefully excised and separated from the surrounding fat tissue 
in a Petri dish with Krebs Henseleit Buffer (KHB). Parts of the aortae were used for 
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organ bath experiments; the rest was frozen in liquid nitrogen and stored at –80 °C for 
subsequent protein determination. 
KHB (Krebs Henseleit buffer), pH 7.4 
NaCl 118.5 mM 
KCl 4.7 mM 
MgSO4 1.2 mM 
KH2PO4 1.2 mM 
NaHCO3 25.0 mM 
CaCl2 2.5 mM 
Glucose 5.6 mM 
 
3.8 Protein Analysis 
3.8.1 Tissue Lysis 
The frozen aortae were minced to powder in a stainless steel mortar and then stored at 
–80 °C. The minced organs and / or the cells from cell culture were lysed in Lysis 
Buffer (LB), approximately 250 µl per 30 µg, for 10 min at room temperature. The 
mixture was vortexed, diluted with the same amount of 2x Rotiload and heated for 
15 min at 95 °C in a thermo-mixer. The emerging samples were stored at –20 °C. 
LB (Lysis Buffer), pH 7.4 
Tris-HCl 40 mM 
NaCl 150 mM 
Sodium deoxycholate 2% (w/v) 
Triton X 100 2% (v/v) 
SDS 0.1% (w/v) 
EDTA 50 mM 
EGTA 50 mM 
Sodium pyrophosphate 50 mM 
Vanadate 2 mM 
2x Complete EDTA-free protease inhibitor set 
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3.8.2 Protein Determination 
According to the method described by Lowry et al. (1951), 10 µl of each sample were 
diluted in 1 ml distilled water and incubated for 10 min with 100 µl of 0.15% sodium 
deoxycholate. After applying 100 µl of 72% trichloracetic acid, the samples were 
incubated for 15 min and then centrifuged with 16000 G for 10 min. The supernatants 
were removed and the pellets were dissolved in 300 µl distilled water and 300 µl 
Folin-I for 10 min. After incubation with 150 µl of 25% Folin Ciocalteu’s phenol 
reagent for 30 min, the optical density of the samples was measured in a 96-well plate 
spectrophotometer (Spectra Max 340 microplate reader, Molecular Devices) at 
595 nm. A BSA serial in different dilutions served as the standard to determine the 
protein concentrations of the samples. All incubation steps were carried out at room 
temperature on an Eppendorf shaker. 
Folin-I 
Na2CO3 224 mM 
NaOH 140 mM 
CuSO4 1 mM 
Sodiumtartrate 2.2 mM 
SDS 2.5% (w/v) 
 
3.8.3 SDS Polyacrylamide Gel Electrophoresis 
Equal amounts of protein were separated at 0.4 mA/cm2 in 9% polyacrylamide gels by 
SDS-PAGE according to the Laemmli method (Laemmli, 1970). The resolving gel 
and the stacking gel on top were generated in Biorad gel casters for gels with 36 
lanes. Then, 40 µg of each sample were loaded on the gel. PeqGold protein marker 
(5 µl) was used for subsequent control of the approximate molecular weight. 
Electrophoresis was performed in a Biorad SDS-PAGE gel chamber at room 
temperature. The samples of each treatment cluster were applied together on one gel. 
To minimize the methodical error (i.e., inexact transfer at the gel margins), the sample 
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order was changed in each electrophoresis. Each Western Blot with one treatment 
cluster was performed four times for each animal. 
Resolving gel (9 %), pH 8.8 
AA-Bis 29.9% (v/v) 
Tris-HCl 375 mM 
SDS 0.1% (w/v) 
Temed 0.05% (v/v) 
APS 0.7% (w/v) 
Stacking gel, pH 6.8 
AA-Bis 16.7% (v/v) 
Tris-HCl 78 mM 
SDS 0.1% (w/v) 
Temed 0.1% (v/v) 
APS 0.5% (w/v) 
Electrophoresis buffer 
Tris 25 mM 
Glycine 192 mM 
SDS 0.1% (w/v) 
 
3.8.4 Western Blot Analysis 
The separated proteins were transferred from the gel to a nitrocellulose membrane 
(Amersham Pharmacia Biosciences, Freiburg) in a semi-dry blotting chamber with 
blotting buffer at 1.2 mA/cm2 for 70 min. After completion of the protein transfer, the 
membrane was stained with Ponceau S, checked on transfer errors (e.g. bubbles) and 
decoloured with TBS-T, in the case it was error-free. Afterwards, the membrane was 
blocked with the blocking solution (2 h, room temperature). 
Primary antibodies (see chapter 3.2.1 and Figure 3) were diluted in blocking solution, 
and the membrane was incubated over night at 4 °C. Then, the membrane was washed 
five times for 10 min with TBS-T, and subsequently incubated with the corresponding 
secondary antibody in blocking solution for 1 h at room temperature. Afterwards, it 
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was again washed five times for 10 min with TBS-T. To visualize the signals, the 
membrane was incubated with ECL Advanced for 5 min, and chemiluminescence was 
immediately recorded with the Kodak Image Station 440 CF. 
 
 
   179 kDa  
   130 kDa  
   100 kDa  
   72 kDa   
   55 kDa   
 
   33 kDa   
 
 
Figure 3: Original blots. From the left to the right, the immunoreactive bands obtained with 
the Nox1, Nox2 and Nox4 antibodies on exemplary blots are shown. 40 µg of rat aortic tissue 
samples were loaded on 9% polyacrylamide gels. Using the PeqGold protein marker, Nox1 and 
Nox4 run at a size of approximately 58 kD, while Nox2 runs at 55 kDa. The last blot on the right 
shows the immunoreactive band of the housekeeping protein β-actin (approximately 35 kDa) 
after stripping off the Nox4 antibody from the membrane. 
 
Immediately after imaging, the membrane was incubated with stripping buffer in a 
water bath for 10 min at 60 °C followed by washing 4 times for 10 min with TBS-T at 
room temperature. Then, the membrane was blocked as mentioned above, before the 
overnight incubation with the next primary antibody could start6. The further 
                                                 
6 It is possible to display the expression of different proteins on one blot by using the corresponding 
antibodies simultaneously, if these proteins are of different sizes, or one after another, if protein bands 
would interfere otherwise. Since the analyzed Nox isoforms are all of a similar size, it was necessary to 
strip the blots before applying the next primary antibody. 
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procedure was the same as described above. All incubation steps were performed on a 
KL 2 shaker.  
Blotting Buffer, pH 10 
Tris-HCl 48 mM 
Glycine 39 mM 
SDS 0.1% (w/v) 
Methanol 20% (v/v) 
TBS-Tween, pH 7.5 
Tris-HCl 20 mM 
NaCl 150 mM 
Tween 20 0.1% (w/v) 
Blocking solution 
2 % (w/v) non-fat dry milk powder in TBS-T 
Stripping Buffer, pH 6.8 
Tris-HCl 69.2 mM 
β-Mercaptoethanol 100 mM 
SDS 2.5% (w/v) 
 
3.8.5 Quantitative Analysis of Protein Immunoblots 
The detected immunoreactive bands were analyzed with the Kodak 1D 3.5 software. 
For quantification, the bands were selected as regions of interest, and band intensity 
was evaluated computer-aided. To compare the protein amount of the different 
samples, the intensity of the bands were normalized to that of the housekeeping 
protein β-actin. 
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3.9 Detection of Superoxide and Nox Activity 
Superoxide detection was performed following the protocol of Li and Shah (2001). 
Cells were trypsinized, washed in PBS and resuspended at 106/ml in HEPES buffer. 
Then, 5 µM lucigenin was added to the cells. This cell suspension was transferred to a 
96-well plate in aliquots of 100 µl. After an incubation period of 20 min at 37 °C, the 
reaction was started by applying 100 µM NADPH to the wells. Chemiluminescence 
was recorded over a time period of 20 min using the Fluoroscan FL microplate reader. 
The values represent the maximum of the recorded light emission. The Nox inhibitor 
apocynin (1 mM) was applied at the maximum of the signal, and the amount of 
inhibition indicated Nox activity. For each group, each experiment was repeated at 
least five times. 
HEPES buffer, pH 7.4 
NaCl 140 mM 
KCl 5 mM 
MgCl2 0.8 mM 
CaCl2 1.8 mM 
Na2HPO4 1 mM 
HEPES 25 mM 
Glucose 1% (w/v) 
 
3.10 Isometric Tension Measurements 
The isometric tension measurements were in principle performed according to the 
protocol of Christon et al. (2005). In a Petri dish with KHB, two aortic rings of 2-
3 mm length were excised from each thoracic aorta and immediately mounted in 
isolated organ bath chambers, which contained 5 ml KHB and were oxygenated 
continuously with carbogen (95% O2 / 5% CO2) at 37 °C. Changes in isometric 
tension were detected by a force transducer and recorded via a 6-channel transducer 
data acquisition system. 
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Figure 4: Isometric tension measurement in one examplary aortic ring. A. Phenylephrine 
(PE)-induced contraction followed by carbachol (CCh)-induced vasorelaxation and washing of 
the ring. B. The enlarged section shows the CCh-induced vasorelaxation. The doses were applied 
after reaching a plateau. The first effect is visible with 100 nM CCh. 
 
The vessels were gradually stretched up to 20 mN. To determine the viability of the 
rings, they were challenged two times with 80 mM KCl. The KCl solution was 
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washed out with KHB after the contraction had reached a plateau. Thus, the rings 
were relaxed back to pretension (20 mN). After a recovery phase of 45 min, the rings 
were contracted submaximally (approximately 80%) with 10 µM of the α-adrenergic 
receptor agonist phenylephrine (PE). When the contraction reached a plateau, the 
rings were relaxed with the endothelium-dependent, parasympathomimetic carbachol 
(CCh) to assess a dose-response-curve (1 nM to 10 µM in semilogarithmic steps, 
cumulative application).  
One complete PE-induced contraction followed by CCh-induced vasorelaxation, as 
demonstrated in Figure 4, took about 120 min. 
Further experiments after preincubation with 100 µM of the Nox inhibitor apocynin 
followed by the procedure described above were performed. Thus, if any difference 
between groups was revealed in the organ bath experiments, the effects of purple 
grape products could have been specified. 
The evaluation of the maximum PE-induced contractions and CCh dose-response-
curves were done using the IBJ-Bemon 32 software. Therefore, the recorded curves 
(Figure 5) were compared with the chronological protocol, and event markers were 
set at the points of interest. Thus, each event (maximum PE-induced contraction, 
response to single doses of CCh) had corresponding values of force, which were 
calculated computer-aided. 
 
3.11 Statistical Analysis 
3.11.1 General Considerations 
Data sampling, descriptive statistics (mean or median as appropriate, standard error of 
the mean, confidence interval, 25% - 75%-interquartil range), and modelling of the 
dose-response-curves were done using Graph Pad Prism 4.0 from Graph Pad Software 
(San Diego, USA). All experimental data presented throughout the study are mean 
values with SEM, unless otherwise stated. Statistical comparison of protein analyses 
was done with the help of Dr. R. H. Bödeker from the department of medical 
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statistics, Justus-Liebig-University, Giessen. A p-value of p < 0.05 was considered to 
be statistically significant (* p < 0.05, ** p < 0.01, *** p < 0.001). 
 
3.11.2 Test Animals 
Descriptive statistics were used to examine the weight gain of animals and the amount 
of fluid and chow ingested. Within the exploratory data analysis, significant 
differences between treatment groups were assessed by ANOVA analysis. In WUR, 
the differences between all groups within a single treatment cluster were tested by 
Bonferroni’s post hoc test. This post-test was chosen, because Gaussian distribution 
was assumed, and because selective columns should be compared with each other (all 
columns within the single treatment clusters). In SHR, only two groups had to be 
compared with each other, so the student’s t-test was used. 
 
3.11.3 Immunoblots 
The Western Blot data of the cell culture experiments are presented as means with 
SEM. Values were normalized to the values of the PBS group, which was set 100%. 
Statistical differences between the means were analyzed by ANOVA followed by 
Bonferroni’s post test which is appropriate in groups with Gaussian distribution. 
The statistic evaluation of the in vivo part of the study required the formation of 
treatment clusters. Each Western Blot of one treatment cluster was performed four 
times. Hence, each animal had four intensity values for each Nox isoform. From these 
values the median was assessed, because the data showed no Gaussian distribution. 
Values were normalized to the values of the water group, which was set to 100%. 
Results are given as medians with 25% - 75%-interquartil range. The groups within 
one treatment cluster were compared using an exact Fligner-Wolfe many-to-one test 
with a control of multiple range testing. This test was considered appropriate because 
of its robustness against potential heterogeneous distributions. In SHR, only two 
groups had to be compared, so the student’s t-test was used. 
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The null hypothesis tested both in the in vitro and the in vivo experiments was as 
follows: There are no differences between the groups or between certain groups of a 
treatment cluster with respect to the expression of a specific Nox isoform. 
The alternative hypothesis was: There are differences between the groups of a 
treatment cluster with respect to the expression of a specific Nox isoform. 
The null hypothesis was to be rejected in the case p < 0.05. 
 
3.11.4 Superoxide Assay 
NADPH-derived superoxide production, expressed as the chemiluminescence signal, 
is represented as means with SEM. Statistical differences were examined by ANOVA 
with Bonferroni’s post test. The amount of the signal that was inhibited by apocynin 
was normalized to the PBS control, which was set to 100%, and differences between 
the means were analyzed using ANOVA followed by Bonferroni’s post test. 
 
3.11.5 Vascular function 
Analysis of vasofunction data was done by descriptive statistics. For analysis of 
isometric tension measurements, the values of the two aortic rings from each animal 
as obtained from the IBJ-Bemon 32 software were averaged. Statistical analysis was 
performed with the Graph Pad software. In WUR, maximum PE-induced contractions 
were compared using ANOVA analysis and Bonferroni’s post test for between-group 
differences. In SHR, the student’s t-test was used. A value of p < 0.05 was considered 
to be statistically significant.  
Sigmoid dose-response-curves for CCh-induced vasorelaxation were attained with the 
following equation: Y=Ymin+(Ymax-Ymin)/(1+10logEC50-X), with X = log(conc) and 
Y = response. This three-parameter sigmoid gave a sufficiently good fit to the 
experimental data in the global curve fitting procedure. Efficacy (maximum response) 
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and potency (EC50)7 were compared with the Akaike’s Information Criterion (AIC) 
test. Before attaining EC50 values by using global curve fitting, the single curves 
were normalized (Ymax = 100%), i.e., by using a global model, all curves shared the 
same maximum response and allowed the comparison of EC50 values. The AIC is 
based on information theory and is considered to be appropriate for the comparison of 
more than two dose-response-curves with respect to EC50 values. It does not compare 
a null hypothesis with an alternative hypothesis, and, therefore, does not give a p-
value. Instead, two models are compared with the AIC method (e.g. model 1 “all 
EC50 are the same” vs. model 2 “all EC50 are different”) resulting in relative 
probabilities wi (“Akaike’s weights”) for each model. A decision between the two 
models can be made with the help of the evidence ratio wi/wj. For example, an 
evidence ratio of 1.6 means that one model is 1.6 times more likely to be correct than 
the other one. Since the AIC does not work with statistical hypothesis testing, it 
cannot be used to reject one model. The term “significance” is inappropriate in this 
context. The AIC test is comprehensibly introduced in “Fitting models to biological 
data using linear and nonlinear regression” (Motulsky and Christopoulos, 2003). 
 
                                                 
7 The curve progression of dose-response-curves is mostly non-linear; in the logarithmic form, the 
curve has a sigmoid shape. The therapeutic range in pharmacology often lies in the intensely rising 
middle segment of the graph. Two values may be obtained from dose-response-curves. The efficacy 
(the response to a substance) is displayed on the ordinate, the potency (the dose that leads to a certain 
response) is displayed on the abscissa. The EC50, a measure for potency, describes the dose that 
exhibits 50% of the maximum effect. It is located at the inflexion point of the sigmoid graph. For 
further explanations see one of the current textbooks of pharmacology, e.g. „Pharmakologie und 
Toxikologie“ (Estler and Schmidt, 2006). 
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4 RESULTS 
4.1 Effects of Purple Grape Products in vitro 
4.1.1 Nox Activity in A7r5 Cell Culture is Decreased by Red Wine 
NADPH-derived superoxide production as a sign of oxidative stress was suppressed 
by purple grape products in rat aortic smooth muscle cells. As demonstrated in 
Table 6, chemiluminescence was significantly lower in A7r5 cells incubated with red 
wine in comparison to the active control ethanol. Red wine treated cells produced 
only half as much superoxide as the cells treated with ethanol (p < 0.001). Multiple 
testing of all groups revealed no significant effect of ethanol itself on superoxide 
production in comparison to PBS. Application of purple grape juice on A7r5 cells 
decreased chemiluminescence to 54% of the control PBS (p < 0.01). 
Table 6: NADPH-derived superoxide production, expressed as chemiluminescence (CL) 
signal, was significantly suppressed in A7r5 cells treated with red wine compared to cells 
incubated with ethanol (p < 0.001), and in cells treated with purple grape juice in comparison to 
PBS (p < 0.01). The apocynin inhibitable part of the CL signal, a measure for Nox activity, was 
significantly affected by red wine in comparison to ethanol (p < 0.05), but not by purple grape 
juice in comparison to PBS. All values display means ± SEM. * displays statistical significance 
in comparison to ethanol and # in comparison to PBS. N ≥ 5 experiments for each group. 
Treatment CL signal Apocynin inhibitable part 
of CL signal 
PBS 252.5 ± 12.2 100 ± 14.4 
Ethanol 321.3 ± 16.7 131.1 ± 30.7 
Red wine 159.8 ± 40.1 *** 48.3 ± 20.9 * 
Purple grape juice 137.2 ± 11.6 ## 60.2 ± 13.2 
 
Apocynin is a known inhibitor of Nox proteins, thus the apocynin inhibitable part of 
the chemiluminescence signal is a measure for Nox activity. Figure 5A shows the part 
of the signal that is inhibitable by apocynin. Incubation with red wine suppressed Nox 
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activity in A7r5 cells in comparison to ethanol to 37% (p < 0.05), but purple grape 
juice did not significantly affect Nox activity in comparison to PBS. The active 
control ethanol also did not alter the apocynin inhibitable part of the 
chemiluminescence signal compared to PBS. 
A 
 
 
 
 
 
B 
 
 
 
 
 
Figure 5: Red wine as well as purple grape juice significantly suppress NADPH-dependent 
ROS production and down-regulate Nox4 immunoreactivity in A7r5 cells. A. NADPH 
oxidase activity was significantly affected by red wine (RW) in A7r5 cells as shown by a 
significant reduction of the apocynin inhibitable part of the chemiluminescence signal as 
compared to PBS. B. Quantitative Western blot analysis revealed a significant down-regulation 
of Nox4 immunoreactive signals in A7r5 cells after incubation with 5% RW (p < 0.001 in 
comparison to EtOH) or 10% purple grape juice (PGJ) (p < 0.001 in comparison to PBS control) 
for 72 h. All values display means ± SEM. * displays statistical significance in comparison to 
EtOH and # in comparison to PBS. N ≥ 5 experiments per group. 
 
  39
4.1.2 Nox4 Immunoreactivity in A7r5 Cells is Down-Regulated by 
Purple Grape Products 
Nox4 is the only vascular Nox isoform that is detectable in A7r5 cells with the 
antibodies that are established in our laboratory. Thus, we only investigated the in 
vitro effects of purple grape products on Nox4 expression. Incubation of A7r5 cells 
with red wine led to a significant down-regulation of Nox4 immunoreactivity in 
comparison to ethanol (p < 0.001), which was revealed by quantitative Western Blot 
analysis (Figure 5B). Ethanol did not significantly affect protein levels in comparison 
to PBS. Incubation with the non-alcoholic beverage purple grape juice significantly 
reduced Nox4 immunoreactivity in A7r5 cells (p < 0.001). The red wine and purple 
grape juice effects on Nox4 both showed concentration-dependency, as shown in 
Figure 6 and Table7.  
 
Table 7: Nox4 immunoreactivity in percentage of PBS control. Red wine was compared to 
ethanol, and purple grape juice was compared to PBS. All values are given as means ± SEM.  
* displays statistical significance in comparison to ethanol and # in comparison to PBS. N ≥ 4 
experiments per group. 
Treatment Concentration (v/v) Nox4 immunoreactivity 
PBS 10% 100 ± 4 
Ethanol 0.6% 104.4 ± 3 
Red wine 1% 85.4 ± 2.6 * 
 2.5% 66.2 ± 6.5 *** 
 5% 71.2 ± 3.3 *** 
 10% 46.1 ± 6.1 *** 
Purple grape juice 1% 104.4 ± 6.1 
 2.5% 88.6 ± 7.3 
 5% 87.7 ± 8.8 
 10% 60.4 ± 2.4 ### 
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Figure 6: Concentration-dependency of Nox4 down-regulation by purple grape products 
in A7r5 cells. A. RW down-regulates Nox4 immunoreactivity in a concentration-dependent 
matter as compared to the EtOH control (0.6%). B. PGJ down-regulates Nox4 immunoreactivity 
in A7r5 cells in a concentration-dependent matter, too, but apparently with a lower potency. Just 
the concentration of 10% PGJ reached statistical significance in comparison to the PBS control 
(10%). All values display means ± SEM. * displays statistical significance in comparison to 
ethanol and # in comparison to PBS. N ≥ 4 experiments per group. 
 
Red wine down-regulated Nox4 immunoreactive signals in all concentrations from 
1% to 10% in comparison to a 0.6% ethanol solution which corresponds to 5% red 
wine. The lowest values were reached after applying 10% red wine in PBS (Figure 
6A). This concentration led to a down-regulation to 44.2 ± 5.9% of control 
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(p < 0.001). Purple grape juice reduced Nox4 immunoreactivity with a lower potency 
than red wine. Figure 6B shows Nox4 signals after applying purple grape juice in 
concentrations from 1% to 10% in comparison to the control PBS. While lower 
concentrations failed to change the signal, the 10% concentration reached a 
statistically significant Nox4 down-regulation to 60.4 ± 2.4% of control (p < 0.001). 
A down-regulation to such an extent was nearly reached by a red wine concentration 
of only 5% (68.2 ± 3.2%, p < 0.001). 
 
4.2 Effects of Purple Grape Products in Living Animals 
4.2.1 General features 
No mortality was observed in any treatment group. 12 weeks old Wistar unilever rats 
(WUR) weighed approximately 330 g (334 ± 5, n = 40) before starting the treatment, 
with no statistically significant difference between the groups. After 14 d, WUR that 
were fed with purple grape products, ethanol or water had gained weight equally. The 
WUR receiving the sugar solution gained more weight in comparison to the water 
control (p < 0.05). The mean (± SEM) weight gains in gram were 39 ± 4 for the water 
and 59 ± 4 for the sugar group. SHR (12 weeks old) weighed approximately 280 g 
(275 ± 8, n = 12) before starting the experiments. At the end of the feeding period, 
SHR had gained weight equally, with no difference between treatment and control 
group. 
WUR ingested equal amounts of water, red wine and ethanol. A remarkable greater 
fluid intake occurred with the two beverages with high sugar content. The animals 
treated with purple grape juice and sugared water drank significantly more than the 
other three groups (p < 0.001). The mean (± SEM) daily amounts in gram were 22.6 ± 
0.8 for water, 34.7 ± 3.0 for purple grape juice, and 55.3 ± 2.4 for sugared water. SHR 
showed a similar drinking behaviour. The mean (± SEM) daily amounts in gram were 
23.9 ± 1.6 in the water group, and 47.3 ± 3.7 in the purple grape juice group 
(p < 0.001). 
The amount of daily-ingested chow did not differ between the four treatment groups 
in WUR, but three of them (red wine, ethanol, sugar) ingested a significantly higher 
  42
amount than the control group water (p < 0.05). WUR fed with purple grape juice did 
not ingest significantly more chow than the water group (p > 0.05). In SHR, there was 
no difference in daily amount of chow between treatment and control group. 
All values concerning weight gain or daily amount of ingested fluid or chow are 
displayed in Table 8. 
Table 8: Animal weight gain as well as daily liquid and chow intake in a 14 d feeding period. 
All values represent means ± SEM. Asterisks demonstrate statistical significance in comparison 
to the water control. N = 8 for WUR, n = 6 for SHR. 
Animals Treatment Weight gain after 
14 days [g] 
Daily liquid intake 
[g] 
Daily chow intake 
[g] 
WUR Water 39 ± 4 22.6 ± 0.8 7.1 ± 0.9 
 Ethanol 38 ± 5 21.4 ± 0.7 14.8 ± 0.8 * 
 Red wine 46 ± 7 22.3 ± 1.1 16.7 ± 0.6 * 
 Purple grape juice 29 ± 4 34.7 ± 3 *** 10 ± 5.2 
 Sugar solution 59 ± 4 * 55.3 ± 2.4 *** 14.2 ± 1.1 * 
SHR Water 22 ± 9 23.9 ± 1.6 25.8 ± 9.4 
 Purple grape juice 33 ± 5 47.3 ± 3.7 *** 21.3 ± 3.6 
 
 
4.2.2 Ethanol but not Red Wine Elevates Nox4 Immunoreactivity in Rat 
Aorta 
The vascular Nox isoforms Nox1, Nox2 and Nox4 were detectable in the thoracic 
aortae of all healthy Wistar unilever rats (WUR) in all treatment groups. 
Figure 7 demonstrates that feeding WUR with red wine or ethanol alone did not result 
in any change of Nox1 or Nox2 protein expression in relation to the control group 
water. In contrast, ingestion of ethanol alone led to a significant up-regulation of 
Nox4 immunoreactive signals to 145% of the values obtained from the group that was 
fed with water (p < 0.05, see Table 9). Treatment with red wine containing the same 
concentration of ethanol (6%) did not significantly up-regulate Nox4 signals 
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compared to water. Correspondingly, Nox4 immunoreactivity in the red wine group 
was significantly lower than in the ethanol group (p < 0.05). Thus, specific 
ingredients of the red wine seem to have prevented the Nox4 up-regulation attributed 
to the ethanol treatment. 
WUR were also treated with purple grape juice. Grape juice ingestion did not change 
the expression of the vascular Nox isoforms Nox1, Nox2 and Nox4 as compared to 
the water treatment (Figure 7 and Table 9). Additionally, the treatment group 
receiving the sugar solution showed no significant alteration in protein levels of any 
investigated Nox isoform. 
Spontaneously hypertensive rats (SHR) were treated with purple grape juice only. 
Ingestion of this beverage did not significantly affect the expression of the 
investigated vascular Nox isoforms in comparison to the control water (Table 9). 
Table 9: Immunoreactivity of vascular Nox isoforms in percentage of water control (= 100%). 
For this table, the values of the water control in WUR were obtained from Western Blots of the 
red wine treatment cluster (water – red wine – ethanol). Western Blots of the other treatment 
cluster (water – purple grape juice – sugar solution) led to similar values. All values are given as 
medians [25% - 75%-interquartil range]. * displays significance in comparison to water and # in 
comparison to ethanol. N = 8 for WUR, n = 6 for SHR. 
Animals Treatment Nox1 Nox2 Nox4 
WUR Water 100 [52.2 - 357.3] 100 [43.1 - 140.2] 100 [71.5 - 146.5] 
 Ethanol 150.2 [127 - 232.6] 79.8 [66.3 - 185] 144.8 [135.1 - 163.9] *
 Red wine 94.9 [77.4 - 183.9] 67.9 [43.2 - 112.4] 123.2 [114.5 - 135.3] #
 Purple grape juice 126.6 [78.6 - 165.4] 134.1 [86.9 - 211.9] 114.1 [104.1 - 158.7] 
 Sugar solution 83.8 [35.1 - 153.9] 112.1 [92.6 - 157.4] 145.8 [110.5 - 162.6] 
SHR Water 100 [32.4 - 301.1] 100 [55.9 - 450.8] 100 [60.1 - 122.7] 
 Purple grape juice 179 [85.1 - 679] 122 [58.4 - 328.6] 109.2 [94.7 - 128.2] 
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Figure 7: Purple grape products do not affect vascular Nox immunoreactivity in Wistar 
Unilever rat aorta in vivo. A. Neither EtOH and the sugar solution nor the purple grape products 
significantly affected Nox1 protein levels in comparison to the water control. B. Nox2 protein 
levels were not influenced by EtOH, RW, PGJ or sugar. C. Quantitative Western blot analysis 
revealed a significant up-regulation of Nox4 immunoreactivity after EtOH ingestion which did 
not occur in the RW group. PGJ and sugar did not significantly affect Nox4 immunoreactive 
signals. Values are given as medians [25% - 75%-interquartil range]. * displays statistical 
significance in comparison to water and # in comparison to EtOH. N = 8 animals for each group. 
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4.2.3 Ingestion of Purple Grape Products Does Not Influence ex vivo 
Vascular Function 
After a feeding period of 14 d, the ex vivo contractility of the aorta was determined by 
measuring phenylephrine (PE)-induced vasocontraction. Aortic rings from WUR 
responded similarly to the step-wise application of PE in all treatment groups and in 
the control group (Figure 8A and Table 10). SHR aortae displayed weaker 
contractility (about 20% less) than WUR aortae. However, the values of the treatment 
and control group in SHR did not significantly differ from each other (Table 10). 
Endothelium-derived vasorelaxation was induced by application of the acetylcholine 
analogue carbachol (CCh). Figure 8B illustrates the CCh-induced course of 
vasorelaxation in percentage of the PE-induced contraction in isolated aortic rings 
from healthy WUR. Neither treatment with ethanol and the sugar solution nor with the 
purple grape products affected endothelium-dependent vasorelaxation (Figure 8B). 
Table 10 demonstrates the EC50 values with 95% confidence interval derived from 
the CCh-dose-response-curves. In the ethanol group, the 95% confidence interval of 
the EC50 value did not overlap with that of the water group. This finding indicated a 
real difference between water and ethanol treatment. Nevertheless, multiple testing 
with the AIC led to an evidence ratio of only 1.31, i.e., the possibility that all curves 
are different is just 1.31 times more likely than the possibility that all curves are the 
same. Thus, no difference could be revealed between the groups. Furthermore, there 
was no remarkable difference between the groups concerning the maximum 
vasorelaxation (Table 10). In fact, the evidence ratio obtained by AIC indicated that 
the possibility that there is no difference between the groups is 1.2 times more 
probable than the alternate model with different maximum values. 
In aortic rings from cardiovascular stressed SHR, CCh-induced vasorelaxation was 
not changed by feeding purple grape juice in comparison to water. EC50 values and 
maximum vasorelaxation did not differ significantly between the groups (Table 10). 
Since no effect of purple grape products on ex vivo vasofunction could be revealed by 
these experiments, further statistical analyses of the data obtained after preincubation 
with the Nox inhibitor apocynin could be omitted. 
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Figure 8: Vascular function is not affected by in vivo administration of purple grape 
products. A. Phenylephrine (PE)-induced contraction of Wistar Unilever rat aortic rings was not 
significantly affected by EtOH, RW, PGJ or the sugar solution. Values are given as means ± 
SEM in % of water control. B. Carbachol (CCh)-induced vasorelaxation was also not affected by 
EtOH, RW, PGJ or the sugar solution. Data points represent means ± SEM. N = 6 animals for 
each group. 
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Table 10: PE-induced vasocontraction (means ± SEM) in percentage of water control, and 
EC50 values (means [95% confidence interval]) as well as maximum vasorelaxation in 
percentage of PE-induced contraction (means [95% confidence interval]) of the CCh-dose-
response-curves. N = 6 for each group. 
Animals Treatment CCh-induced vasorelaxation 
  
PE-induced 
vasocontraction EC50 [nMol] Maximum relaxation 
WUR Water 100 ± 4.9 152 [81 – 282] 65 [58 – 73] 
 Ethanol 88.1 ± 11.6 521 [293 – 929] 59 [51 – 67] 
 Red wine 94.4 ± 7.8 407 [185 – 891] 64 [53 – 75] 
 Purple grape juice 95 ± 8.3 158 [58 – 427] 64 [53 – 74] 
 Sugar solution 98.9 ± 8.1 319 [195 – 523] 77 [69 – 85] 
SHR Water 100 ± 7.9 34 [19 – 59] 67 [62 – 73] 
 Purple grape juice 84.6 ± 10.6 19 [9 – 43] 67 [61 – 74] 
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5 DISCUSSION 
5.1 The in vitro Role of NADPH Oxidases in the French 
Paradox 
A reduction of oxidative stress caused by red wine polyphenols is suggested to be a 
key factor leading to the improved cardiovascular health in France. Oxidative stress 
results in NO breakdown and endothelial dysfunction, one initial event in the 
development of hypertension and atherosclerosis, which may result in acute events 
like myocardial infarction and ischemic stroke (Ross, 1999). A variety of studies 
support the hypothesis that a modulation of the oxidative homeostasis is at least in 
part responsible for the French paradox (Freedman et al., 2001; Vinson et al., 2001; 
Al-Awwadi et al., 2004). 
The main sources of vascular ROS are xanthine oxidase, uncoupled eNOS and 
NADPH oxidases. Xanthine oxidase seems to be involved in cardiovascular diseases 
like hypertension and atherosclerosis (Erdei et al, 2006; Yamamoto et al., 2006). 
Nevertheless, research on this enzyme is complicated by the fact that it generates ROS 
as a by-product of the catalyzation of hypoxanthine / xanthine to uric acid. The role of 
eNOS, which acts as a contributor to oxidative stress if it is uncoupled, in the French 
paradox was investigated extensively. Still, the published results are controversial 
(Bernátová et al., 2002; Ralay Ranaivo et al., 2004). The last of the mentioned ROS 
sources, NADPH oxidases, represent a young field of research. Their role in the 
French paradox has not been investigated in detail yet. Nevertheless, the previous 
results are promising (Orallo et al., 2002; Ying et al, 2003). In this study, we, 
therefore, tried to illuminate the role of NADPH oxidases as main sources of vascular 
ROS in the mechanism of the French paradox. 
Purple grape juice has been propagated to exhibit the same or even more pronounced 
beneficial effects than red wine (Vinson et al., 2001). Since it does not contain ethanol 
with its deleterious side effects, grape juice appears to be more appropriate for 
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prophylaxis of cardiovascular diseases than red wine. For that reason, we investigated 
the influence of both red wine and purple grape juice on vascular NADPH oxidases. 
The first step was the investigation of possible effects of polyphenolic liquids on Nox 
expression and activity in vitro. Fur this purpose, the rat aortic smooth muscle cell 
line A7r5 was incubated with the purple grape products red wine and purple grape 
juice in PBS with the respective controls ethanol and PBS. Since vascular Nox 
isoforms are main contributors to ROS, their activity was estimated using superoxide 
measurement. Interestingly, both red wine and purple grape juice significantly 
suppressed NADPH-derived superoxide production to approximately 50%. A7r5 cells 
incubated with red wine produced 49.7% of the amount of superoxide measured after 
incubation with ethanol. Purple grape juice led to the generation of 54.3% superoxide 
in comparison to PBS.  
As described above, Nox are not the only producers of superoxide in vasculature. 
Thus, a Nox inhibitor added to the cells at the maximum of light emission could 
indicate Nox activity by the amount of inhibition. The frequently used apocynin was 
chosen as the appropriate substance, because it was the most specific inhibitor 
available at the time these experiments were performed. This substance inhibits Nox 
activity in phagocytic cells by blocking the assembly of the subunits to form the 
active enzyme complex (Simons et al., 1990). It was also described to inhibit Nox 
activity in non-phagocytic cells like endothelial cells (Meyer et al., 1999), but newer 
data are contradictory with the last point. After examining the effect of apocynin on 
NADPH oxidase activity in leukocytes, endothelial cells and VSMC, Heumüller et al. 
(2008) supposed that apocynin predominantly acts as an antioxidant in the last two 
cell types. 
The apocynin inhibitable part of the chemiluminescence signal was significantly 
reduced by treatment with red wine. It reached only 36.8% of the inhibited part after 
incubation with ethanol. Assuming that apocynin is a Nox inhibitor in vascular 
smooth muscle cells, these findings indicate that the suppressed ROS generation in 
A7r5 cells treated with red wine is due to a reduced Nox activity. This result was not 
surprising, since Deby-Dupont et al. (2005) reported a reduced Nox activity in 
monocytes infected with Chlamydia pneumoniae after 19 h incubation with diverse 
red wine polyphenols. However, purple grape juice did not statistically significantly 
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affect the apocynin inhibitable part of chemiluminescence (PGJ: 60.2 ± 13.2, PBS: 
100 ± 14.4, p = 0.07). Thus, the decrease in ROS production cannot be explained 
solely by a reduced Nox activity. There are other contributors of vascular ROS, in 
particular uncoupled eNOS that was discussed to be implicated in the French paradox 
(Wallerath et al., 2002; 2003; 2005; Bernátová et al., 2002). Possibly, the reduced 
oxidative stress caused by purple grape products is not due to suppressed Nox activity 
alone, but to simultaneous effects on different enzyme systems. 
We proved that purple grape products suppress the generation of superoxide in 
vascular smooth muscle cells, and that red wine – if apocynin indeed acts as a Nox 
inhibitor in this experimental setting – reduces Nox activity in the same cells. To 
confirm these statements, we quantified the immunoreactive signals of Nox protein in 
A7r5 cells after incubation with red wine, purple grape juice and the respective 
controls. Nox4 is the only vascular Nox isoform that is detectable in A7r5 cells with 
the antibodies established in our working group. We suspected that red wine would 
suppress Nox4 immunoreactivity8, because it was able to diminish ROS production by 
a reduced Nox activity. Indeed, red wine treatment reduced Nox4 signals to 68.2% of 
the signal obtained after incubation with ethanol. Ethanol itself did not influence 
Nox4 in comparison to PBS. Surprisingly, purple grape juice led to a significant 
reduction of Nox4 signals to 60.4% of the levels reached by incubation with only 
PBS. It seems that vascular NADPH oxidases are at least involved in the effects of 
purple grape juice on oxidative stress, although the effect on NADPH oxidase activity 
was not strong enough to reach statistical significance (p = 0.07). 
Another interesting aspect of this study is the evidence for concentration-dependency 
of Nox4 down-regulation by purple grape products. Both, red wine and purple grape 
juice decreased Nox4 immunoreactivity in a concentration-dependent matter. Red 
wine at a concentration of 1% was sufficient to reduce the signals significantly to 
81.8% of control. The strongest reduction (44.2% of control) was achieved by a 10% 
concentration. In contrast, purple grape juice seems to influence Nox4 with a lower 
                                                 
8 For the reason mentioned in chapter 3.2.1 we describe the signals obtained with this antibody as 
immunoreactive signals. 
  51
potency. While a 10% concentration down-regulated Nox4 to 60.4% of control, all 
concentrations up to 5% did not significantly affect Nox4 immunoreactivity. 
The findings that grape juice acts with a lower potency than red wine both on protein 
level and in its influence on Nox activity is contradictory to a study from Fitzpatrick 
et al. (1993), in which different grape products were tested and compared concerning 
their vasorelaxing activity in vitro, and in which purple grape juice was a much 
stronger vasodilator than the red wine tested. However, the present work investigated 
the effects of purple grape products on cells after a 72 h incubation period, whereas 
Fitzpatrick et al. (1993) examined the immediate effects of the substances on vessel 
walls.  
 
5.2 Discrepancy between in vitro and in vivo Findings 
Our findings in the in vitro part of the study indicated that vascular Nox isoforms, in 
particular Nox4, play an important role in the French paradox. So we were 
encouraged to verify these results by in vivo application of purple grape products.  
Healthy male Wistar unilever rats (WUR) are a widespread used outbred rat strain in 
multidisciplinary research (see the HsdCpb:WU data sheet from Harlan, 
www.harlaneurope.com). In addition, the cardiovascular stressed spontaneously 
hypertensive rats (SHR) are an established model for genetic hypertension. SHR were 
developed from Wistar rats by selective breeding of hypertensive animals (Lerman et 
al., 2005). Male SHR develop systolic blood pressures of more than 200 mmHg with 
an age of 8 – 10 weeks (Stasch et al., 1987). In these animals, hypertension is 
associated with decreased nitric oxide bioavailability due to excessive ROS 
generation in the vessel wall (Schnackenberg et al., 1998), and with endothelial 
dysfunction and impaired vasorelaxation (Zalba et al., 2000). The increased ROS 
production seems to originate from vascular Nox isoforms, because Nox activity and 
p22phox mRNA expression are elevated in SHR vessels (Zalba et al., 2000; Cai et al., 
2003). Additionally, our working group found evidence for enhanced Nox1 and Nox2 
protein levels in SHR compared to Wistar rats (Wind, 2006).  
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To elucidate the in vivo role of Nox proteins in the beneficial effect of purple grape 
products, we determined the immunoreactivity of three vascular Nox isoforms, Nox1, 
Nox2 and Nox4, following different feeding conditions including red wine and purple 
grape juice, with ethanol and sugar solution as additional “active” controls. Moreover, 
vasofunction was investigated in aortic rings of the same animals. 
We chose a 50% concentration for the red wine, because it was described to be 
effective in literature (Bentzon et al., 2001; Vinson et al., 2001), and because pure red 
wine certainly does not meet the condition of “moderate alcohol consumption”. Since 
purple grape juice was only half as potent as red wine in down-regulating Nox4 
protein levels in the foregoing in vitro experiments, we chose a 100% concentration 
for the juice. Pure purple grape juice was also administered by Osman et al. (1998) 
without exhibiting any harmful effect in dogs and monkeys. 
When healthy WUR were fed with red wine or purple grape juice for 14 days, we 
found no statistically significant change in the protein expression of any investigated 
Nox isoform. Thus, our in vitro findings, which revealed evidence for a decrease in 
Nox4 immunoreactive signals after incubation of aortic smooth muscle cells with 
purple grape products, could not be confirmed in the in vivo part of this study.  
For the in vivo experiments, we used the same type of red wine and purple grape juice 
that exerted effects in the in vitro experiments. Apparently, there is some difference 
between in vivo and in vitro application of grape polyphenols. Many studies on the 
French paradox have investigated different parameters in vitro only, without verifying 
the results in vivo. In general, ingestion of polyphenolic beverages leads to polyphenol 
plasma levels that are much lower than the polyphenol concentrations that are 
achievable, when these liquids are directly applied to the cells or organ preparations. 
In fact, it has been reported that the bioavailability of ingested polyphenols was rather 
low in humans (Duthie et al., 1998) and in rats (Xu et al., 2004). To overcome the low 
bioavailability of polyphenolic compounds, high orally amounts are needed to achieve 
plasma concentrations in the range of those used in in vitro experiments. 
In the present in vivo study, the animals ingested 22 ml of a 50% red wine solution per 
day. The mean content of polyphenols in red wine is very variable, and we do not 
know the definite amount of polyphenols in the red wine we used. Sarr et al. (2006) 
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reported that 2.9 g polyphenolic extract was produced from one litre red wine 
(Corbières A.O.C.). Using these data and taking into account the 1:1 dilution of the 
red wine in water, the daily intake of polyphenols in our experiments was about 
80 mg/kg/d. However, this amount was divided into many small bulks by the drinking 
behaviour of the animals during 24 h. As a result, the intragastral amounts of 
polyphenolic compounds remained constantly low in our test animals, and 
accordingly low were presumably the plasma levels of the polyphenols. Diebolt et al. 
(2001), who found an enhanced vasorelaxing effect with an extract of red wine 
polyphenols in Wistar rats, directly administered this extract into the stomach of rats. 
So the intragastral concentrations of polyphenols had one high peak each day. It 
cannot be ruled out that in the present study plasma concentrations of the food-
derived polyphenols were constantly too low to exhibit significant effects on Nox 
protein expression. 
While we did not find any down-regulation in protein expression of the vascular ROS 
producers Nox1, Nox2 and Nox4 after treating male WUR with purple grape 
products, we found an up-regulation of the Nox4 immunoreactive signals in the 
ethanol group. This elevation of the Nox4 immunoreactive signals was statistically 
significant as compared to the water control and, in addition, to red wine (both groups 
belonged to one treatment cluster together with the ethanol group). To our knowledge, 
an increase in Nox4 protein expression has not yet been described in the literature. 
Polikandriotis et al. (2006), who investigated the harmful effects of alcohol, reported 
an increase in Nox2 protein expression in lung tissue of Spraque Dawley rats after 
administration of ethanol for six weeks, which had also resulted in enhanced 
pulmonal superoxide generation. In contrast, we did not find a change in Nox2 protein 
expression. That discrepancy may be attributed to the different organs investigated, 
i.e. aortic tissue in our study and lung tissue in that of Polikandriotis et al. (2006). 
Furthermore, the amount of ethanol in the described study was rather high with 36% 
of the daily-ingested calories in a liquid diet. 
Our findings that ethanol but not red wine treatment enhances Nox4 immunoreactive 
signals suggest that some components of the red wine are able to prevent the harmful 
effect of ethanol. The most favourite candidates for these components are surely the 
polyphenols. In this context, the result of a normal Nox4 expression in animals treated 
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with red wine as compared to ethanol appears to contradict our previous assumption 
that oral administration of red wine would not result in sufficient polyphenol plasma 
levels. Possibly, metabolization of ethanol or its effect on Nox protein is altered in the 
presence of accompanying polyphenols. Another explanation derives from the 
aforementioned study of Sarr et al. (2006). The authors reported an inhibition of 
angiotensin II-induced Nox1 protein overexpression in Wistar rats after ingestion of 
red wine polyphenols (administered in the drinking water), but no change of Nox1 
expression in animals not pretreated with angiotensin II. In other words, red wine 
polyphenols did only affect pathologically enhanced Nox1 protein levels and had no 
effect on normal Nox1 expression in healthy animals (Sarr et al., 2006). These 
findings of Sarr et al. (2006) are in agreement with our results. We found elevated 
Nox4 immunoreactive signals in rats stressed with ethanol, which did not occur when 
ethanol was accompanied by the non-alcoholic components of red wine. While 
angiotensin II elevates Nox1, ethanol increases Nox4 signals. In both cases, red wine 
polyphenols and / or red wine itself are apparently able to prevent the overexpression 
of these Nox proteins. 
If the observed difference in Nox4 immunoreactivity was in fact caused by the 
polyphenols in red wine, then these polyphenols must have reached the endothelium 
in levels sufficient to prevent the overexpression of Nox protein. The polyphenol 
plasma level, however, might not be high enough to significantly reduce the normal 
expression of the Nox proteins assessed. 
SHR, which were used in this study as a model for cardiovascular diseases, show an 
overexpression of Nox1 and Nox2 protein in aorta (Wind, 2006). In this context, SHR 
are very similar to angiotensin II-treated rats that were shown to overexpress Nox1 
(Sarr et al., 2006). Unfortunately, for animal welfare reasons, we were not allowed to 
treat these cardially stressed hypertensive animals with the potentially harmful red 
wine (cf. chapter 3.1). So we do not know, whether red wine would also reduce the 
pathological Nox overexpression in these animals. Moreover, by accident9, we did not 
                                                 
9 Enough animals were ordered from Harlan Winkelmann GmbH in Borchen, Germany. Half of them 
arrived dead in one cage. The other twelve animals were healthy, which was attested by the 
veterinarian of the animal house (“Zentrales Tierlabor”), Dr. Ina Schepp. After the usual adaption 
period they were assigned to two instead of three treatment groups. 
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have enough animals to form a third treatment group to control the sugar intake. Since 
ingestion of the sugar solution did not result in any effect on Nox protein expression 
in WUR, there would probably be no alteration in protein levels in SHR, too. 
Nevertheless, no statistically significant change in Nox protein expression was 
apparent in SHR treated with purple grape juice when compared to water treatment. 
There are three possible explanations for this finding, and none of them appears more 
reasonable than the other: (1) The amount of absorbed polyphenols was to small to 
exert significant effects on the pathological Nox expression in these animals. (2) 
Purple grape juice polyphenols are not able to affect Nox overexpression in the same 
way as red wine polyphenols. (3) SHR do not react like angiotensin II-treated rats 
with respect to their overexpression of Nox proteins. 
 
5.3 Organ Bath Studies on Aortic Vasofunction 
In order to give our findings concerning Nox protein expression functional relevance, 
we performed ex vivo vessel studies using the same animals10. NADPH oxidases 
produce ROS and are involved in oxidative stress, which in turn is linked to 
endothelial dysfunction. In organ bath experiments, we assessed endothelial 
dysfunction by impairment of endothelium-derived vasorelaxation in response to 
carbachol (CCh). This synthetic compound is an analogue of the natural transmitter 
acetylcholine and leads to an endothelial NO release via muscarinerg M3-receptors. If 
purple grape polyphenols would have beneficial vascular effects, then vasorelaxation 
should be improved compared to control. Conversely, in animals not treated with 
polyphenolic liquids, inferior vasorelaxations should indicate the deleterious effects of 
ROS-producing enzymes like Nox proteins. In order to confirm, whether potential 
differences among groups were due to Nox proteins, the tension measurements have 
been repeated in the presence of the Nox inhibitor apocynin. Thus, Nox-dependent 
differences would vanish. 
                                                 
10 For practical reasons, organ bath studies were performed immediately after dissecting the aortae. 
Protein determination was done afterwards with the rest of the thoracic aortae. 
  56
In this experimental setting it was important to verify that precontraction with 
phenylephrine (PE) was not influenced by different treatments of animals. In fact, we 
found no significant difference between the groups with regard to PE-induced 
contraction. Thus, contraction of aortic rings was not influenced by a possibly altered 
Nox protein activity or other interfering effects, including ethanol. 
In a recently published paper, Tirapelli et al. (2006) reported an increased contraction 
after treating Wistar rats with ethanol for two or more weeks, contrary to our study in 
which neither ethanol nor red wine had an effect on PE-induced vasocontraction. That 
discrepancy may be due to the different amounts of ethanol used for feeding. Tirapelli 
et al. (2006) administered 20% ethanol in water, whereas we burdened the animals 
just with 6% ethanol, either alone or in the form of red wine. The concentration of 6% 
was considered to be a relatively realistic model for the simulation of modest red wine 
consumption. Feeding in this manner corresponds to a drinking behaviour in which 
half of the ingested fluid is red wine or a comparable alcoholic beverage. In contrast, 
Tirapelli et al. (2006) tried to mimic alcohol abuse rather than modest consumption – 
the amount of ethanol corresponding to spirits being half of the ingested fluid. 
Since there were no significant differences in PE-induced contraction among the 
treatment groups, the subsequent experiments on CCh-induced vasorelaxation due to 
NO could be adequately analysed for real treatment effects. Overall, we found no 
beneficial effects on aortic vasofunction in association with feeding of purple grape 
products for 14 days. These findings were in accordance with our later obtained 
results for Nox immunoreactivity. 
Considering our protein expression data, CCh-induced vasorelaxation should only be 
impaired in the animals treated with ethanol, because only ethanol led to an increase 
of the expression of ROS-producing Nox4 protein. A measure for the degree of 
impairment is given by the EC50 value obtained from the dose-response-curve. 
Hence, EC50 is a measure of the potency of CCh to induce vasorelaxation. If its 
potency is reduced, higher concentrations of the drug are needed to produce the same 
degree of vasorelaxation, resulting in a higher EC50 value. A reduction in CCh 
potency can be due to a decreased NO bioavailability under conditions of oxidative 
stress. In fact, the concentration of CCh needed to produce half maximal relaxation 
(EC50) was markedly increased (3.4-fold) solely in the ethanol group as compared to 
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the water control with no overlap in the 95% confidence interval. Since four parallel 
treatment groups had to be compared to one control group, a global statistic method 
including all five groups had to be used. We, therefore, applied Akaike’s Information 
Criterion (AIC) to the five data sets, and found that a global model implying different 
EC50 values was only slightly more probable (1.3-fold) than an alternative model 
using the assumption that all EC50 values were the same. These findings might be 
conflicting with respect to the ethanol group, which showed a significant elevation of 
Nox4 signals. However, an alteration of protein immunoreactivity determined by 
Western Blotting is not an evidence for a change in protein activity determined by 
functional experiments like vessel studies. 
The results obtained with SHR correspond to those obtained with WUR, even though 
at different levels. First of all, PE-induced maximum contraction was lower in SHR 
than in WUR aortic rings. This well-known observation is related to the thickened and 
more rigid vessel walls of the hypertensive animals (Gendron et al., 2004). When 
endothelium-derived vasorelaxation was investigated, the EC50 value, but not the 
maximum relaxation, was considerably lower than in WUR. The increased sensitivity 
to CCh was accompanied by an inverse effect of CCh on vasorelaxation at 
concentrations higher than 1 µM. The drug itself possibly caused this decline in 
relaxation. These findings confirm a study published by Yang et al. (2004). In the 
course of their studies on endothelium-derived contractions due to the parasympathic 
acetylcholine in high concentrations in aortae from SHR and normotensive controls, 
they found acetylcholine-induced vasocontraction in aortic rings from SHR but not 
from Wistar rats (Yang et al., 2004). Nevertheless, our results clearly show that 
treatment with purple grape juice for 14 days did not improve NO-dependent 
vasorelaxation in SHR aortic rings as compared to water control. 
While our findings did not indicate a change in endothelium-derived vasorelaxation 
caused by red wine or purple grape juice, different other studies have demonstrated an 
improved vasorelaxation evoked by red wine with and without alcohol as well as 
different other polyphenolic grape products, but not ethanol alone (Fitzpatrick et al., 
1993; Zenebe et al., 2003; Duarte et al., 2004). However, these experiments were all 
performed in vitro, and the examined substances were directly applied to the vessel 
rings. Thus, polyphenols were present at relatively high concentrations and, because 
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of their antioxidant properties (Tapiero et al., 2002), could act directly against ROS, 
thereby enhancing NO bioavailability. In our study, a change in vasorelaxation would 
result from diet-induced intracellular modification of the protein expression, which in 
turn would affect the function of the endothelium. 
In other studies, red wine extracts were orally administered to Wistar rats. These 
extracts were given either by intragastral gavage at a dose of 20 mg/kg/d for 7 d 
(Diebolt et al., 2001) or in the drinking water at a dose of 150 mg/kg/d for three 
weeks (Sarr et al., 2006). Diebolt et al. (2001) could demonstrate an ameliorated ex 
vivo vasorelaxation in healthy rats. Sarr et al. (2006) reported such an improvement in 
animals showing endothelial dysfunction due to angiotensin II treatment, but not in 
healthy rats, although they treated with a very similar red wine extract as Diebolt et al. 
(2001) for a period three times as long. As considered in chapter 5.2, the different 
outcomes with respect to endothelium-derived vasorelaxation in healthy rats of these 
two studies and our work might be due to the different manners of administration 
(intragastral application with daily peaks [Diebolt et al., 2001] versus administration 
in drinking water with constantly low intragastral levels [this work; Sarr et al., 2006]). 
In addition, there is some doubt that results obtained with polyphenolic extracts are 
directly comparable to those obtained with native red wine. These extracts, which are 
produced by methods like freeze-drying from selected vine varieties (van Golde et al., 
2004), may show a higher effectiveness than native red wine polyphenols that are 
embedded in a complex system of hundreds of different compounds. 
In literature, there is evidence for a beneficial effect of purple grape juice on 
vasculature, but only few papers report on both purple grape juice and red wine. 
Fitzpatrick et al. (1993) found a similar endothelium-dependent vasorelaxation 
following direct in vitro application of both substances on rat aortic rings. We could 
not confirm these findings in ex vivo organ bath studies. In this study, purple grape 
juice did not influence vasofunction in WUR and SHR, neither regarding PE-induced 
contraction nor CCh-induced endothelium-derived relaxation. 
 
  59
5.4 Relevance of NADPH Oxidases in the French Paradox 
In this study, we provided evidence for the in vitro effects of the purple grape 
products red wine and purple grape juice on Nox activity and Nox4 immunoreactivity. 
However, we could not confirm these findings in vivo, neither in healthy Wistar rats 
nor in cardiovascular stressed SHR. Moderate consumption of red wine or purple 
grape juice did not reduce the immunoreactive signals of Nox1, Nox2 or Nox4 protein 
in rat aortae. Moreover, both red wine and purple grape juice failed to exert a 
beneficial effect on endothelium-derived vasorelaxation. The only potential benefit of 
red wine polyphenols observed was the prevention of an overexpression of Nox4, 
which was induced when ethanol alone was given to Wistar rats. 
As mentioned above, many publications concerning the French paradox investigated 
different parameters in vitro without verifying them in vivo. Especially in 
vasofunction experiments, it is easier to apply the substances of interest directly on 
the vessels. Since polyphenols have antioxidant properties and thereby enhance NO 
bioavailability, it is not surprising that they improve vasorelaxation. This may also 
occur in vivo after oral administration. However, in experimental settings designed to 
show a persistent effect of the ingested polyphenols on vasofunction, the direct 
actions of antioxidants are irrelevant. In these cases, an improvement in vasofunction 
can be derived from certain changes in the vessel wall. Such an improved 
vasorelaxation in rat aortic rings ex vivo has been reported by Diebolt el al. (2001) and 
Sarr et al. (2006). However, in these studies polyphenolic extracts were used. In this 
context it seems noteworthy that many biological properties of polyphenols and their 
metabolites are not precisely known yet. Thus, a systematic research on the impact of 
single polyphenols or special combinations of them on the French paradox is still 
difficult. That will become apparent if we bring to mind the great and almost 
confusing variety of investigated substances in French paradox research. In many 
cases it is not clear, why just these specific polyphenols have been used (e.g. Leikert 
et al., 2002; Benito et al., 2004), suggesting that the selection was done rather at 
random than scientifically justified. 
In the present study, the animals were treated with native red wine instead of 
polyphenolic extracts. Moreover, the amounts delivered were comparable rather to 
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modest than to excessive red wine consumption, thus mimicking the drinking customs 
of the French more realistically. In doing so, we found no indications of an improved 
vasorelaxation of rat aortic rings ex vivo, and there was also no significant decrease in 
aortic Nox protein expression in vivo. Hence, the question arises, whether vascular 
NADPH oxidases are in fact involved in the beneficial effects that have been 
attributed to the red wine. Despite of this, there are many findings which may support 
this assumption, even though Nox isoforms are a very young field of research. The 
scientific rationale for the research on Nox isoforms is based on the generally 
accepted concept that oxidative stress plays a crucial role in cardiovascular morbidity. 
Orallo et al. (2002) were the first who implicated NADPH oxidases in the French 
paradox. They reported that the polyphenol resveratrol has caused a decrease of 
NADPH-dependent superoxide production in aortic tissue homogenates. Shortly after, 
Ying et al. (2003) demonstrated that green and black tea polyphenols reduced p22phox 
and p67phox protein expression in vitro. The subunit p22phox is known to be essential 
for activity of all vascular Nox isoforms (Azumi et al., 1999), but p67phox only seems 
to be required for Nox2 activation (Nisimoto et al., 1999; Takeya et al., 2003; 
Ambasta et al., 2004; Martyn et al., 2006). Although regulatory subunits are required 
for the activation of vascular Nox isoforms, their expression alone is not sufficient to 
produce ROS. Furthermore, an enhanced p22phox expression can be associated with all 
vascular Nox isoforms, so an exact characterization of the specific involved Nox 
isoform is hard to prove. Thus, the interpretation of the findings of Ying et al. (2003) 
is difficult. Recently, new antibodies raised against the catalytic vascular subunits 
Nox1 and Nox4 were generated (Wingler et al., 2001). Additionally, there are some 
different commercial Nox2 antibodies. Hence, it seems reasonable to examine the 
impact of the catalytic Nox isoforms itself instead of only that of their regulatory 
subunits. Apart from our present study, there is just one other work that has assessed 
the role of a catalytic subunit (Nox1) in the French paradox (Sarr et al., 2006). With 
the present study, we investigated the in vitro and in vivo effect of the polyphenolic 
beverages red wine and purple grape juice on all catalytic Nox isoforms that were 
known to occur in vessels at this time. 
The fact that we could not confirm the findings of our in vitro experiments, which 
indicated an involvement of NADPH oxidases in the French paradox, in vivo might 
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favourite a totally different hypothesis for the French paradox. Law and Wald (1999), 
for example, demonstrated that mortality from cardiovascular diseases was mainly 
correlated to the intake of animal fat. Some decades before, the consumption of 
animal fat was rather low in France. But the fraction of animal fat in the typical 
French diet has enhanced over the last decades. Law and Wald (1999) stated that there 
is a time lag between the increase in animal fat intake and the following increase in 
cardiovascular mortality. This time lag could be responsible for the apparent paradox, 
because today’s mortality corresponds to animal fat intake of 30 years ago (Law and 
Wald, 1999). Provided that the time lag hypothesis is true, then the French paradox 
should diminish within the next few decades. 
Although the French paradox is commonly related to red wine consumption, this 
association may be confounded by other parameters, because red wine drinkers tend 
to be less fat, to exercise more, and to drink with meals (Goldberg et al., 2001). The 
latter aspect seems to be of importance, because wine consumption has been shown to 
reduce the postprandial endothelial dysfunction induced by a high fat meal (Blanco-
Colio et al., 2000). The acute administration of red wine along with a high-fat meal 
reduced the increase in NF-κB, a nuclear transcription factor that induces several 
genes for inflammatory proteins including C-reactive protein (CRP). This effect was 
not seen with vodka, the other alcoholic beverage investigated in this study (Blanco-
Colio et al., 2000). 
Finally, the data of two large studies strongly exclude a selective benefit from red 
wine in the American population (Klatsky et al., 1997; Gaziano et al., 1999). Klatsky 
et al. (1997) followed mortality in 128934 Californians enrolled in a health 
maintenance organization for 13 years with respect to their total and type of alcohol 
consumption. At 13 years of follow-up, there was no evidence for any selective effect 
of red wine (Klatsky et al., 1997). In a Boston area case-control study of 340 subjects, 
Gaziano et al. (1999) followed the incidence of myocardial infarction according to the 
type of alcohol consumed. Again, no significant differences were observed by the 
type of alcohol. 
Nevertheless, there is cumulating evidence that the ingestion of polyphenolic 
foodstuff and beverages has some beneficial impact on cardiovascular health, at least 
if these compounds are ingested in pharmacological effective doses. Polyphenols have 
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been shown to exhibit specific effects on different vascular parameters. One of these 
effects is the inhibition of Nox activity and Nox4 protein expression in vitro, as 
demonstrated in this study. Modest consumption of red wine alone may not be 
sufficient to produce significant cardioprotective effects on the investigated 
parameters in vivo. This assumption is supported by our experiments.  
Thus, the origin of the French paradox cannot be explained by vascular NADPH 
oxidases. Hitherto, other experimental designs failed to conclusively identify possible 
pathways, too. Further investigation is required in this appealing field of research to 
bring light in the molecular mechanisms of the French paradox. 
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6 SUMMARY 
The term French paradox stands for the epidemiologically proven fact that the French 
suffer less from cardiovascular morbidity and mortality than other people with a 
comparable fat intake. This paradox was attributed to the rather high red wine 
consumption of the French. Several studies have stated a beneficial influence of 
purple grape products on oxidative stress. Since NADPH oxidases are one of the main 
contributors to vascular reactive oxygen species, we experimentally examined the 
effect of the purple grape products red wine and purple grape juice on Nox protein 
and activity in vitro and in vivo. 
The immunoreactivity of the vascular Nox isoforms Nox1, Nox2 and Nox4 in rat 
aortic tissue homogenates and of Nox4 in rat vascular smooth muscle cells (VSMC) 
following administration of red wine and / or purple grape juice was assessed. Nox 
activity was determined via measurement of superoxide production in VSMC and by 
performing isometric tension measurements on isolated rat thoracic aorta segments. 
The in vivo experiments were performed in healthy Wistar unilever rats (WUR) and in 
spontaneously hypertensive rats (SHR), which serve as a disease model for genetic 
hypertension. 
In vitro incubation with red wine and / or purple grape juice led dose-dependently to 
decreased Nox4 immunoreactive signals and to a lower superoxide production in 
VSMC. The apocynin inhibitable part of superoxide generation, a measure for Nox 
activity, was reduced by red wine only. However, oral treatment with both purple 
grape products did not significantly affect Nox protein levels in WUR. Surprisingly, 
ingestion of ethanol resulted in Nox4 overexpression, which did not occur with red 
wine. Ex vivo endothelium-derived vasorelaxation in organ bath chambers was not 
influenced by ingestion of purple grape products in WUR. Treating SHR with purple 
grape juice affected neither Nox protein expression nor vasofunction. 
The findings of this study strongly point out the discrepancy between in vitro and in 
vivo experiments in French paradox research. While direct application of purple grape 
products on VSMC had distinct effects on both Nox activity and protein expression, 
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in vivo administration of the same liquids did not affect Nox protein expression and 
vasofunction. Thus, the origin of the French Paradox cannot be explained by NADPH 
oxidases. Since other experimental designs also were not able to conclusively identify 
possible pathways, the molecular mechanism of the French paradox is still unclear. 
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7 ZUSAMMENFASSUNG 
Das „Französische Paradox’“ bezeichnet die Beobachtung, dass Frankreichs 
Bevölkerung im Vergleich zu anderen Nationen trotz eines ähnlich hohen alimentären 
Fettanteils eine geringere kardiovaskuläre Morbidität und Mortalität aufweist. Dieses 
Paradox wird mit dem ausgeprägteren Rotweinkonsum in Frankreich erklärt. Diverse 
Studien konnten eine positive Wirkung von Rotwein auf den für kardiovaskuläre 
Erkrankungen mitverantwortlichen oxidativen Stress nachweisen. NADPH-Oxidasen 
stellen eine der Hauptquellen für reaktive Sauerstoffspezies im Gefäßsystem dar. 
Daher untersuchten wir in dieser Studie den Einfluss von Rotwein und rotem 
Traubensaft auf die Expression und Aktivität von NADPH-Oxidasen in vitro und in 
vivo. 
Nach Inkubation glatter Gefäßmuskelzellen mit Rotwein, Traubensaft bzw. den 
entsprechenden Kontrollen wurde die NADPH-abhängige Bildung von Superoxid in 
An- und Abwesenheit des Nox-Inhibitors Apocynin sowie die Immunoreaktivität von 
Nox4 im Western Blot bestimmt. Des Weiteren wurden gesunde Wistar-Unilever-
Ratten (WUR) mit den oben genannten Substanzen behandelt, spontan hypertensive 
Ratten (SHR) erhielten Traubensaft bzw. Wasser als Kontrolle. Die Aktivität der 
NADPH-Oxidasen wurde auf indirektem Wege ex vivo an Aortensegmenten im 
Organbad untersucht. Ferner wurde die Proteinexpression der vaskulären Nox-
Isoformen Nox1, Nox2 und Nox4 quantifiziert. 
Die Inkubation glatter Gefäßmuskelzellen sowohl mit Rotwein als auch mit rotem 
Traubensaft führte dosisabhängig zu verminderten Nox4-Signalen im Western Blot 
sowie zu einer verringerten Bildung von Superoxid. Der Anteil der Superoxidbildung, 
der durch zusätzliche Applikation von Apocynin gehemmt werden konnte – ein Maß 
für die Aktivität der NADPH-Oxidasen –, wurde lediglich durch Rotwein reduziert, 
während roter Traubensaft keinen signifikanten Einfluss zeigte. Nach Behandlung 
gesunder Ratten mit den gleichen Substanzen konnte hingegen keine Veränderung der 
Expression der vaskulären Nox-Isoformen Nox1, Nox2 und Nox4 nachgewiesen 
werden. Überraschenderweise führte jedoch die Gabe von Ethanol zu einer 
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signifikanten Überexpression von Nox4, die nach Rotweingabe nicht auffiel. Auch 
auf die Ergebnisse der ex vivo durchgeführten Gefäßstudien wirkte sich eine vorherige 
Behandlung mit Rotwein oder Traubensaft nicht aus. Die Behandlung von SHR mit 
Traubensaft beeinflusste im Vergleich zur Kontrolle weder die Nox-Proteinexpression 
noch die Gefäßreaktivität. 
Die Ergebnisse dieser Studie verdeutlichen die Diskrepanz zwischen in vitro- und in 
vivo-Experimenten, inbesondere in der Frage nach möglichen Ursachen für das 
„Französische Paradox“. Während die direkte Applikation von Rotwein und 
Traubensaft sowohl die Aktivität als auch die Proteinexpression der NADPH-
Oxidasen beeinträchtigte, konnten wir nach in vivo-Gabe derselben Substanzen 
keinerlei Reaktionen nachweisen. Somit scheint das „Französische Paradox“ über 
NADPH-Oxidasen nicht erklärbar zu sein. Auch andere experimentelle Ansätze 
konnten bisher nicht schlüssig mögliche, zu Grunde liegende Wege aufdecken. Die 
molekularen Mechanismen des „Französischen Paradox“ bleiben daher weiterhin 
offen. 
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9 ABBREVIATIONS 
 
A Ampere 
aa Amino acid 
AA-Bis Acrylamide Bisacrylamide 
AIC Akaike’s Information Criterion, statistical test  
ANOVA Analysis of variances 
APS Ammonium peroxodisulphate 
BSA Bovine serum albumine 
CaCl2 Calcium chloride 
CCh Carbachol (carbamoylcholine) 
cGMP Cyclic guanosine monophosphate 
CI Confidence interval 
CO2 Carbon dioxide 
CuSO4 Cupric sulphate 
EC50 Required concentration to reach 50% of maximum effect 
ECL Enhanced chemiluminescence 
EDRF Endothelium-derived relaxing factor 
EDTA Ethylene diamine tetraacetic acid 
e.g. Exempli gratia 
EGTA Ethylene glycol tetraacetic acid 
eNOS Endothelial nitric oxide synthase 
FAD Flavin adenine dinucleotide 
FMN Flavin mononucleotide 
G Gravity 
gp91phox Glycoprotein with a size of 91 kDa, subunit of phagocytic oxidase 
GTP Guanosine triphosphate 
HCl Hydrochloric acid 
HDL-C High density lipoprotein cholesterol 
HEPES Hydroxyethyl piperazin ethan sulfonic acid 
H2O2 Hydrogenperoxide 
HOCl Hypochlorous acid 
HRPO Horse radish peroxidase 
i.e. Id est 
KCl Potassium chloride 
kDa Kilodalton 
KHB Krebs Henseleit Buffer 
KH2PO4 Potassium hydrogenphosphate 
LB Lysis buffer 
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LDL-C Low density lipoprotein cholesterol 
M Molar (mol/l) 
MgSO4 Magnesium sulphate 
mRNA Messenger ribonucleic acid 
N Newton 
NaCl Sodium chloride 
Na2CO3 Sodium carbonate 
NADPH Nicotinamide adenine dinucleotide phosphate, reduced form 
NaHCO3 Sodium hydrogencarbonate 
NaOH Sodium hydroxide 
NO Nitric oxide 
NOS Nitric oxide synthase 
Nox Catalytic subunit of NADPH oxidases 
n.s. No statistic significance (p ≥ 0.05) 
O2- Superoxide anion 
-OCl Hypochlorite 
OH- Hydroxyl radical 
ONOO- Peroxynitrite 
OxLDL-C Oxidized low density lipoprotein cholesterol 
p Probability 
p47phox Protein with a size of 47 kDa, subunit of phagocytic oxidase 
PAGE Polyacrylamide gel electrophoresis 
PE Phenylephrine 
pH Pondus / potentia hydrogenii 
ROS Reactive oxygen species 
SDS Sodium dodecylsulphate 
SEM Standard error of means 
SHR Spontaneously hypertensive rats 
SOD Superoxide dismutase 
TBS-T Tris-buffered saline with Tween 
TCA Trichloroacetic acid 
Temed N,N,N,N-tetramethyl ethylene diamine 
Tris 2-Amino-2-hydroxymethyl-1,3-propanediol 
VSMC Vascular smooth muscle cell 
WUR Wistar unilever rats 
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